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CHAPTER 1
Introduction
8 Introduction
1.1 Background
Electromagnetic fields (EMF) have been a vital part of our daily life for over a century
now and their application in society is still increasing. EMF continuously surround us
and are generated by many different sources in various situations like domestic devices,
telecommunication systems, electric power transmission lines, but also in medical applic-
ations such as Magnetic Resonance Imaging (MRI), transcranial magnetic stimulation
in psychological disorders, deep brain stimulation in Parkinson disease and hyperther-
mia treatment of cancer. The rapid increase worldwide in the use of EMF results in an
increased awareness of the general public for the risks associated to exposure to EMF,
which raised concerns about possible adverse health effects associated to exposure at the
currently applied levels. In response to these public concerns, in 2006 the Dutch govern-
ment initiated a research program on electromagnetic fields and health (EMF&H). The
research presented in this thesis is performed within the framework of this program and
was aimed at investigating the appropriateness of the currently applied safety limits in
relation to the changes in organ functionality under controlled conditions and at well
quantified exposure levels.
The current guidelines for maximum human exposure to EMF have been defined by the
International Commission on Non-Ionizing Radiation Protection (ICNIRP) and the Insti-
tute of Electrical and Electronics Engineers (IEEE). These guidelines define basic restric-
tions (BRs) that protect against established adverse effects due to whole-body or partial
body exposure to EMF. The BRs are conservative, i.e. incorporate large safety factors, to
assure that threshold dose levels, at which biological effects have been established, are not
exceeded. However, the selection of safety factors is an arbitrary process based on expert
opinion rather than a rigorous quantitative process. In addition, the magnitude of the ac-
tual safety margin for various exposure scenarios is unknown since these exposure limits
and safety factors have been obtained by animal experiments or from assessments that ap-
proximated the human anatomy by simple shapes and homogeneous materials. Therefore,
it is questionable if the exposure limits are adequate or over restrictive. If over restrictive,
this would imply that the limits can be increased for improving the functionality of the
exposure purpose, e.g. EMF based diagnosis or therapy.
1.2 Electromagnetic exposure and health effects
To understand the biological effects of electromagnetic (EM) radiation, we should first
understand the difference between ionizing radiation and non-ionizing radiation (Figure
1.1). Ionizing radiation is radiation that carries enough energy to remove an electron from
an atom or molecule, thereby ionizing them. The Deoxyribonucleic acid (DNA) molecule
of living cells is always susceptible to damage by ionizing radiation. Non-ionizing radiation
refers to any class of electromagnetic radiation that does not carry enough energy to ionize.
Still non-ionizing radiation excites the motion of the atoms or molecules when absorbed
by matter.
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The work described in this thesis is limited to localized exposure of humans to non-ionizing
electromagnetic fields at the radio frequency (RF) spectrum, that is 100kHz to 3 GHz.
Figure 1.1: Electromagnetic spectrum classification, the associated biological effects
and examples of exposure sources. Created using elements taken from
www.wikipedia.org
1.2.1 Interaction mechanism
The interaction of EMF with materials, e.g. human tissues, depends on their frequency.
In the RF range, the EMF energy absorption and subsequent tissue heating becomes the
major mechanism89.
RF EMF energy absorption is based on oscillating mechanical forces on electric charged
particles or electric dipoles generated by the electric component, and, generated by the
magnetic field component on particles with an inherent magnetic moment88. Depend-
ing on the particles mass and mobility, these forces may cause translatory, oscillatory
and/or rotatory movement and hence conversion of field energy to particles kinetic en-
ergy. Particles kinetic energy is then distributed inside the material by collision with
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other particles, hence causing irregular particle movement that on a macroscopic scale
is phrased as “heat” (Browns molecular movement) and quantified by the physical term
temperature.
A detailed description of bio-electromagnetics can be found for example in Durney 23 .
1.2.2 Health effects of RF EMF
In 2011, the Working group at the International Agency for Research on Cancer (IARC)
reviewed many studies regarding associations between use of wireless phones and glioma
to assess the carcinogenicity of RF EMF. Overall, the Working Group concluded that
there is “limited evidence” for the carcinogenicity of RF EMF. In view of the limited
evidence in humans and in experimental animals, the Working Group classified RF EMF
as “possibly carcinogenic to humans” (Group 2B)27. Most recently, the results of the
major US National Toxicology Program (NTP) animal research project on the effects of
chronic exposures to mobile phone signals were made public and an increased occurrence
of malignant gliomas in the brain and schwannomas of the heart in male rats chronically
exposed to RF EMF was reported109. The authors say, “These findings appear to support
the IARC conclusions regarding the possible carcinogenic potential” of RF EMF. However,
these effects were not observed in female rats and exposed male and female rats lived
longer than the controls. This study is currently under review and the results are far from
definitive at this point. Even before the IARC started its project, the EMF Committee of
the Health Council of the Netherlands initiated a systematic analysis of the epidemiogical
literature on this subject. Its conclusions are slightly different from those of IARC. The
Committee concludes that from this evidence there is no established association between
long-term and frequent use of a mobile telephone and an increased risk for tumors in
the brain or head and neck. Such association can however also not be excluded. The
Committee considers it unlikely that exposure to RF EMF associated with the use of
mobile phones, causes cancer. At present, there is still much uncertainty and contradiction
about the health risk of EMF and probably this confusion in both scientific and public
community will not disappear on short notice.
Current guidelines for limiting RF EMF exposure have been developed only based on
“established” effects. An established adverse health effect is referred to a biological effect
characterized by a harmful change in health that is supported by consistent findings of
that effect in studies published in the peer-reviewed scientific literature. The effect must be
confirmed with evidence being demonstrated by independent laboratories and consensus
in the scientific community that the effect occurs for the specified exposure conditions.
To date, the only established effect attributed to RF EMF exposure is the acute thermal
effect. The majority of studies that reported non-thermal effects were performed at high
levels of RF exposure and it cannot be exclude that the effects observed are not the
result of heating and elevated temperature57. The few studies that reported effects at low
(non-thermal) exposure levels, i.e. below the recommended limits, are inconsistent and/or
are counterweighted by the larger body of evidence reporting no effects at these exposure
levels. In addition, many of these experiments have serious shortcomings in the dosimetry,
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exposure control and technical lay-out.
1.2.3 Basic restrictions and safety factor
In accordance to IEEE∗ (2005)57 and ICNIRP† (1998)55, restrictions on exposure to
time-varying electric, magnetic, and electromagnetic fields are termed “basic restrictions
(BRs)”. These restrictions are based on established acute health effects and biological
considerations. Protection against acute health effects should be assured if the dose inside
the human body does not exceed the basic restrictions. Depending upon the frequency
of the field, the physical quantities used to specify these restrictions are magnetic flux
density, current density, specific absorption rate (SAR), and power density. For the RF
range, the limits are given in SAR and follow the ICNIRP guidelines from 199855 (Table
1.1). The basis for the the BRs for localized exposure (Table 1.1) is to limit induced tem-
perature rise below 1◦C over 30 minutes in any part of the body for all exposure scenarios.
Table 1.1: Basic restrictions for localized exposure at frequencies between
100 kHz and 3 GHz.∗
General public exposure Occupational exposure
Localized SAR (W/kg) Localized SAR (W/kg)
Head and Trunk 2 10
Extremities 4 20
and pinnae
* Note:
1. All SAR values are to be averaged over any 6-min period.
2. Localized SAR averaging mass is any 10 g of tissue (defined as a tissue
volume in the shape of a cube); the maximum SAR so obtained should be
the value used for the estimation of exposure.
3. The extremities are the arms and legs distal from the elbows and knees,
respectively.
In establishing the basic restrictions, large safety factors are employed to avoid any acute
health effects during exposure with a sufficiently wide margin to account for uncertainty
in the scientific data and interpersonal variability. The term “safety factor” is commonly
interpreted to be the ratio of an exposure level causing an adverse effect to the correspond-
ing defined exposure limit. For example, a whole-body averaged SAR (SARwb) of 4 W/kg
for 30 minutes in an RF exposure experiment has been shown to induce a whole-body
temperature increase of 1◦C which can have adverse health effects such as heat exhaustion
∗Institute of Electrical and Electronics Engineers
†International Commission for Non-Ionizing Radiation Protection
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and heat stroke76. A traditional safety factor of 10 has been applied to this established
SAR level, resulting in a SARwb of 0.4 W/kg for the basic restrictions concerning occupa-
tional environment, see Figure1.2. The occupational population consists of trained adults
under controlled conditions whereas general public consists of individuals of all ages and
various health status. Therefore, more strict restrictions for the public than for the oc-
cupational population is considered, i.e. an additional safety factor of 5 for the public.
The tolerable SAR level for localized exposure is much larger than the SAR limit for a
whole-body exposure. Experimental studies in the late 1970’s have shown that the peak
SAR in a biological body can be more than 20 times higher than the SARwb
38,42,44 with
the same safety factor presumed but not verified or demonstrated to exist for whole-body
exposure. These data form the basis for the localized SAR restrictions. It is believed that
for localized RF exposure, these standards incorporate at least a safety factor of 10 and
probably considerably more if the remarkable tolerance in human studies1 is accepted as
generally valid. However, the magnitude of the safety factors, as ratio between the level
of local SAR that causes adverse effect and the BRs, are not known and quantified for
various localized exposure scenarios.
0.08
0.4
1
2
3
4
10x 50x
SARwb
(W/kg)
1ºC in 30 min
occupation
general pubic
Figure 1.2: Illustration of lowering the established adverse effect SAR level to the
defined SAR limits in the guidelines by applying safety factors on whole-
body averaged specific absorption rate (SARwb), as an example. (Source:
J.F.Bakker, 2012. Dosimetry of exposure to electromagnetic fields in daily
life and medical applications. PhD Thesis, Erasmus MC.).
1.2.4 EMF Dosimetry
EMF Dosimetry is the assessment of the absorbed dose in tissue induced from exposure
to EMF. The dose is measured, or predicted by computational simulations in quantities
such as electric fields, SAR or temperature increase.
According to ICNIRP and IEEE guidelines, accurate dosimetry is essential for meaningful
investigations for biological effects of EMF, since even uniform exposures lead to non-
uniform absorption in almost all in-vivo and in-vitro exposure situations. Many studies
in literature suffer from lack of scientific detail, defective measurements and inadequate
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dosimetry. Absence of dosimetry makes a study impossible to evaluate, or replicate at
comparable levels. Hence, while of interest, these studies cannot be applied to setting
standards for maximum allowable human exposure to RF energy.
Dosimetry has become very reliable and successful by developments in numerical methods
of calculation, e.g. the finite-difference time-domain (FDTD) technique, and by improve-
ments in creating human models based on detailed MRI scans from the human anatomy.
Advanced simulation tools can be used to estimate the induced SAR and temperature
doses following RF energy deposition in human tissue. It is important to investigate the
uncertainty associated with dosimetry when predicting the induced dose in tissues. Un-
certainty is defined as the amount by which the estimated value may depart from the
true value due to the uncertainties in input modelling parameters such as dielectric and
thermal tissue properties and model discretization on the dosimetric results.
1.3 Topics of this thesis
The goal of this thesis is to explore the relevance of the current basic restrictions for
functional tissue changes and to define SAR values for localized RF EMF exposure in
different controlled scenarios above which tissue damage takes place.
This project‡ started at Erasmus MC jointly with Technical University of Eindhoven
(TU/e) in response to increasing public concern about potential adverse health effects of
electromagnetic fields. The project was aimed to investigate possible hazardous impact of
electromagnetic fields on humans by providing high quality dosimetric assessment.
Therefore, as a first step, we verified the dose accuracy in the studies that reported
adverse health effects at the recommended level of EM exposure, i.e. below the maximum
allowable exposure. Among various possible health effects, the risk of inducing brain
cancer from exposure to mobile phone radiation has the strongest interest of laymen and
health organizations. Some epidemiological studies on mobile phone RF EMF exposure
raised questions regarding an increased risk of glioma in heavy users of mobile phones11,12.
However, the investigation of risk of brain cancer associated with mobile-phone use poses
complex methodological challenges in the conduct of the research and in the analysis
and interpretation of the findings. The RF exposure assessments in the brain in those
studies was based on a simple homogeneous phantom that approximated the human head
morphology. In this thesis, we hypothesized that such an approach is bound to a large
uncertainty in the assignment of the exposure level on an individual person. We showed
that individual head morphology is highly diverse and therefore morphological variation
should be taken as an important source of uncertainty into account to calculate an accurate
dose estimation in the brain, .
As next steps, we retrospectively performed dose-effect relations studies at exposure levels
above the guidelines for the brain and eyes, i.e. critical organs when determining safety
guidelines for RF radiation. These organs receive a considerable dose of RF radiation
during hyperthermia treatment of cancer in head and neck region. Hyperthermia (HT),
‡supported by the Netherlands Organization for Health Research and Development (ZonMw)
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a powerful cancer treatment modality, which applies prolonged (60 minutes) intense RF
energy to increase tumor temperature towards 40 to 44◦C, is an example of a therapeutic
application where potential acute effects of EMF on humans can be observed. This thesis
shows that while exceeding the basic restrictions by up to at least 10 (brain2) and 14
(eyes3) times, no indication for any serious acute effect was found. Therefore, as a final
step, the concept of functional SAR limits was developed to help decision making on how
much the local SAR can be increased before acute effects take place.
The goal of this thesis was accomplished by quantifying the safety factor included in the
basic restrictions and developing a concept for functional SAR limits for various localized
exposure scenarios. The safety factors were calculated as a ratio between functional SAR
limits, based on the lowest thermal dose required to induce tissue damage reported in the
literature, and the basic restrictions. The numerical results demonstrate that the margin
of safety in the current basic restrictions for localized exposure is large.
1.4 Outline of this thesis
Chapter 2 describes the assessment of the impact of head morphology on the induced
local SAR in the brain from exposure to mobile phone radiation (below the basic
restrictions).
Chapter 3 describes the evaluation of the conservativeness of the basic restrictions by
retrospectively relating the induced EM dose in the human brain to the scored acute
health effects from exposure to prolonged intense RF EMF during head and neck
hyperthermia.
Chapter 4 describes the evaluation of the conservativeness of the basic restrictions by
retrospectively relating the induced EM and thermal dose in the human eyes to the
scored acute health effects from exposure to prolonged intense RF EMF during head
and neck hyperthermia.
Chapter 5 describes the quantification of the incorporated safety factors in the basic
restrictions by providing functional SAR thresholds associated to the thermal dose
limits above which thermal tissue damage occur.
Chapter 6 provides the general conclusions and future perspectives.
CHAPTER 2
Impact of head morphology on the local brain specific absorption
rate from exposure to mobile phone radiation
This chapter is based on:
F Adibzadeh,JF Bakker, MM Paulides, RF Verhaart and GC van Rhoon. Impact of Head Morphology
on Local Brain Specific Absorption Rate from Exposure to Mobile Phone Radiation.
Bioelectromagnetics, Vol. 36(1), pp. 66-76, 2015.
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Abstract
Purpose: Among various possible health effects of mobile phone radiation,
the risk of inducing cancer has the strongest interest of laymen and health
organizations. Recently, the Interphone epidemiological study investigated the
association between the estimated Radio Frequency (RF) dose from mobile
phones and the risk of developing a brain tumor. Their dosimetric analysis
included over 100 phone models but only two homogeneous standard head
phantoms. So, the potential impact of individual morphological features on
global and local RF absorption in the brain was not investigated. In this
study, we performed detailed dosimetric simulations for 20 head models and
quantified the variation of RF dose in different brain regions as a function
of head morphology. Materials and methods: Head models were exposed
to RF fields from generic mobile phones at 835 MHz and 1900 MHz in the
’tilted’ and ’cheek’ positions. To evaluate the local RF dose variation, we
used and compared two different post-processing methods, i.e. the Talairach
and field-sensor methods. Results: The results show that the variation in the
averaged specific absorption rate (SAR) among the heads can reach up to 16.4
dB at a 1 cm3 cube inside the brain (field-sensor method) and alternatively up
to 15.8 dB in the medulla region (Talairach method). The maximum variation
of 10g peak spatial SAR (psSAR10g) was around 4 dB in the head and 7
dB in the brain. Conclusions: In conclusion, we point head morphology
as an important uncertainty source for dosimetric studies of mobile phones.
Therefore, any dosimetric analysis dealing with RF dose at a specific region
in the brain (e.g. tumor risk analysis) should be based upon real morphology.
2.1 Introduction
The possible health effects of mobile phone radio frequency (RF) exposure are subject of
an ongoing debate in several scientific studies. Because brain tumor incidence has drawn
the most attention, epidemiological approaches are being used to investigate the potential
association between mobile phone RF exposures and the risk for developing brain tumors.
The largest and the most recent study was the Interphone study11,12, in which Cardis and
her colleagues analyzed the risk for brain tumors as the total cumulative specific RF
energy, or dose, absorbed at the tumor locations. By taking more parameters into ac-
count (e.g. telephone type, network characteristics, and amount and conditions of phone
use), they greatly improved on the dose estimation provided by the previous Japanese
Interphone study93. However, the shortcoming of the Interphone study is that dosimetric
measurements were limited to two generic head phantoms, which excluded the potential
impact of head morphological differences on the RF dose in the brain.
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Morphological differences in models is an important source of variation as it has been
illustrated in several studies which employed more than one human model, e.g. (Hirata
et al 2007, Buccella et al 2007).
The main objective of our study was to investigate the variation in averaged specific ab-
sorption rate (SAR) in specific brain-regions due to morphological changes, i.e. changes
in head size and shape. To be able to quantify the relative importance of morphology
compared to other previously investigated dosimetric uncertainty sources (e.g. type of the
mobile phone, phone positioning, age-dependent dielectric properties and pinna thick-
ness), we also assessed the variation in 10g peak spatial-averaged SAR (psSAR10g) in the
brain and head. Finally, additional simulations with altered settings were used to assess
the expanded numerical uncertainty of the results.
2.2 Materials and methods
In this study, detailed dosimetric simulations were performed using SEMCAD X∗. We
used and compared two different methods to evaluate the local RF dose variation from
exposure to generic mobile phones at 835 and 1900 MHz and for ’tilted’ and ’cheek’
positions. First, we assessed the averaged SAR over various brain regions. Second, we
compared the SAR of each specific region between 20 head models and calculated the
SAR variation. Third, we assessed the influence of morphology on psSAR10g which is the
frequently used parameter in mobile phone dosimetric studies. Finally, to investigate the
overall uncertainty of the numerical modeling, we determined the influence of various
modeling parameters on the obtained result (in terms of psSAR10g).
2.2.1 Anatomical head models
Anatomical head models of 20 patients, including 13 males and 7 females, were obtained
from Computed Tomography (CT) images (imaging resolution ranging from 0.58x0.58x1.5
mm3 to 0.97x0.97x2.5 mm3). Each set of CT images was segmented into nine different
tissue types (air, bone, fat, muscle, brain, spinal cord, eye, cartilage and lung) with the
segmentation protocol as described in98, using iSeg†. Note that with this protocol the
brain was segmented as one homogeneous tissue.
Table 2.1 includes more detailed information on the physical characteristics of the head
models relative to human variation. To avoid the impact of imaging methods e.g. CT vs
magnetic resonance imaging (MRI) and to have an equal number of segmented tissues for
all models, we did not include other models (e.g. Virtual Family models). Hence, number
and types of tissues as well as the assigned properties were the same for all of the models.
∗SEMCAD X EM Simulation, version 14.8.4 (www.semcad.com).
†iSeg version 3.5 (www.zurichmedtech.com/products/sim4life/iseg/iseg/).
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Table 2.1: Physical characteristics of the anatomical head models in this study with
comparison to literature values (4 and84).
Brain vol ANT 1∗ ANT 2∗∗ ANT 3∗∗∗ Subjects
Avg std Avg std Avg std Avg std Sex Age
Poston 2000 - - 21.4 0.8 22.5 0.9 14.0 0.6 2208 F 17%≤20
1774 M 21≤57%≤30
17%≤20
Allen 2002 1.2 0.1 - - - - - - 23 F Avg=32.1
23 M std=8.8
This study 1.4 0.1 22.2 0.6 20.7 0.9 15.4 0.5 7 F Avg=61.8
13 M std=11.1
Head Anthropometry (ANT):
∗Pronasale to back of head ∗∗Menton to top of head ∗∗∗Bitragion breadth
Dimensions:
Brain vol.: (l), ANT: (cm), Age: (yr)
2.2.2 Phone models
The generic mobile phone model and the positioning procedure of the phone against the
anatomical heads were as defined in60, in which the authors defined the standard ’cheek’
and ’tilted’ phone positions for anatomical head models by determining reference points
and reference planes based only on the anatomical characteristics of the head model
(Figure 2.1). The phone was modeled as a flat metallic plate representing the printed
circuit board (PCB) inside a plastic box, and a mono-pole antenna. For generality, details
of real phones were not included.
2.2.3 Electromagnetic modeling
The dielectric properties of tissues were assigned to the segmented tissues according to
the ITIS material parameter database∗ 48. The dielectric property of the homogeneous
brain was set to the average for the white matter, grey matter and cerebellum. The brain
permittivity and conductivity were equal to 47.94 and 0.80 (S/m) respectively at 835 MHz
and equal to 45.44 and 1.27 (S/m) at 1900 MHz. For all evaluations we used the finite
difference time domain (FDTD) solver of SEMCAD X. The mesh resolution was between
0.5 mm and 2 mm for the head region and up to 12 mm in air. For all simulations the
mobile phone was fixed and aligned with the grid, and the head model was rotated to
obtain ’cheek’ or ’tilted’ positions (Figure 2.1). The mobile phone was on the left side
of the heads. The antenna was excited by a sinusoidal signal of 10 periods, where steady
∗http://www.itis.ethz.ch/database
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(a) sagittal view (b) cheek (c) tilted
Figure 2.1: Overview of phone positions against the head in (a) sagittal view (b)
’cheek’ and (c) ’tilted’ positions.
state conditions were reached after 6 periods.
2.2.4 Post processing
For post-processing, we used two different evaluation methods.
Field-sensor
In this method, we placed cube field sensors in the brain of each model, i.e. 16 sensors
were used as a compromise between capturing spatial variation in the entire brain and
complexity of the analysis. The size and shape of the sensors were selected to match the
estimated volume of the tumor-center in12, which was a 1cm3 cube. The rationale for
the sensor location was to capture the area where the brain tumor occurrence is more
frequent. Therefore, since the number of gliomas located at frontal and temporal lobes
are substantially higher than for other lobes in adults66, we put more field sensors in these
regions to increase the probability of capturing the center of a possible tumor. In addition,
we put some sensors in other locations (e.g. occipital lobe) to assess the variation in other
brain regions as well.
The field sensors were placed inside the brains prior to phone positioning and based on the
CT image registration using optimized settings from28. Based on this method, we defined
the brain of model number 12 as reference, and registered all the other brains to that. As
a result, spatial correspondence was obtained between all brain models, meaning that the
field sensors were at equivalent locations in the brains. Figure 2.2a shows the location of
the sensors in the brain.
We calculated the average SAR in these sensors as total loss divided by the total lossy
mass, and compared the result per sensor between all head models.
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(a) Positions of the field sensors in the brain.
(b) Basic brain anatomy †and segmentation of the brain in ’Lobe’ and ’Gyrus’ levels.
Figure 2.2: Overview of our 2 post-procession methods: (a)field-sensor (b)Talairach.
Talairach atlas
To evaluate the result of field-sensor method and to be able to extend the SAR variation
assessment to all brain regions, with different shapes and sizes of the averaging volume we
used the Tailarach Atlas tool, available in SEMCAD X package. This tool is based on a
set of landmarks for mapping every position in the brain model into the Talairach atlas67
and vice versa. The location of these landmarks is determined by the brain boundaries
and the position of some inner brain structures16. Since in the models, detailed brain
tissues were not segmented, we aligned and slightly scaled the brain of Duke from the
virtual family (VF)¶ to each brain of our anatomical head models in order to artificially
locate the position of some brain tissues to be able to post-process the data. Note that
the VF model was inserted after simulation and therefore had no influence on the power
absorption in the brain.
The Talairach tool can identify over a thousand different regions in the brain for the
†Source: (http://skpascoe.hubpages.com/hub/Know-Your-Loaf)
¶http://www.itis.ethz.ch/vip
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purpose of characterizing the electromagnetic exposure of anatomical and functional brain
regions16. It subdivides the brain into 1150 different sub-regions, and, according to each
of the five defined levels, assigns a volume occupancy Talairach (VOT) label to each
sub-region. For example, according to hemispherical level, 7 labels are assigned to the
sub-regions, the lobe level defines 12 labels, the gyrus level 55, the tissue level 3, and the
cell level 71. Figure 2.2b provides an overview of the brain subdivision of the lobe and
also of the gyrus levels.
For levels like cell or gyrus, the brain sub-regions are small and mapping the location of
the Talairach regions is more affected by the EM simulation grid or the brain delineation
error16. Therefore, we excluded these levels from our analysis and reported the results
only for the hemispherical, lobe and tissue levels.
We calculated the variations among the heads for each defined region per Talairach-level.
2.2.5 Additional analyses
Peak spatial-average SAR
The psSAR10g in the head and brain were evaluated in a cubic volume according to the
procedure defined in58. We derived it directly in SEMCAD X and compared its values
between different models.
Numerical uncertainty
To investigate the uncertainty of the numerical modeling, we determined the influence of
various modeling parameters on the head psSAR10g for the first model in cheek position
and at 835 MHz as defined in94. The variation of the outcome was assumed predictive for
the overall effect of modeling parameters. The investigated parameters were:
(1) Model discretization: The effect of spatial resolution in the model discretization was
investigated by simulating the maximum grid steps between 1.4 mm and 12 mm.
The effect of using a uniform grid step was also investigated by using additional simula-
tions with uniform grid steps of 0.8, 1 and 2 mm.
(2) Absorbing boundary: We investigate the effect of UPML efficiency by changing the
level of strength in SEMCAD X (low, medium, high, very high).
(3) Simulation time: Additional periods of the harmonic wave, from 10 periods to 50, were
used.
(4) Padding: We increased the padding from λair/4 to λair/2.
(5) Tissue dielectric properties: The individual tissue properties deviate from the mean
literature values proposed by Gabriel33,36,37. Different sources are defined for this deviation
such as age-dependent, tissue assignment, the 4-Cole-Cole dispersion model37 uncertainty
and post mortal changes. The most effective source however is the age-dependent tissue
property variation6. Bakker mentioned that although the influence of other sources is
unknown, we know that the variations are much smaller than the age-dependent dielec-
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tric changes. The influence of age-dependent changes of tissue dielectric properties on
psSAR10g for mobile phone exposure was calculated by
13, who used age-dependent dielec-
trics of grey matter for all brain sub-regions and found that at 900 MHz, the psSAR10g
variation is approximately 0.5 dB.
(6) Image resolution: The CT scan of the first head-model (0.97×0.97×2.5 mm3) was
re-sampled into the resolutions of the other models: 0.97 ×0.97 ×1.5, 0.88 ×0.88 ×2.5,
0.86 ×0.86 ×1.5, 0.76 ×0.76 ×1.5, 0.68 ×0.68 ×1.5, 0.58 ×0.58 ×2.5 and 0.58 ×0.58 ×1.5
mm3.
(7) Segmentation of brain tissues: The influence of detailed brain tissue (grey, white mat-
ter and cerebrospinal fluid) segmentation on our results was calculated by comparing
the value of head psSAR10g for three of the patients (model number 12, 13 and 14) for
whom MR scans were also provided. Thus for each of these three models the difference in
psSAR10g was calculated between heterogeneous- versus homogeneous-brain models. The
average of the differences is reported in table 2.2.
Table 2.2: Evaluation of the standard combined uncertainty uc and the expanded un-
certainty U of the psSAR10g. k is the coverage factor for the confidence
interval.
psSAR10g
% dB
Discretization
(a) non-uniform grid 9.79 0.40
(b) uniform grid 6.56 0.27
Absorbing boundary (ABC) 0.26 0.01
Simulation time 0 0
Padding 0.04 0
Tissue dielectric properties 12.20 0.5
Image resolution 6.15 0.26
Segmentation of brain tissues 0.63 0.03
uc 16.82 0.67
U (k=2) 33.64 1.26
2.2.6 Quantification parameters
The dosimetric variation is quantified by two parameters, i.e. the coefficient of relative
variation (CRV) and the ratio of the maximum to the minimum.
The CRV is the standard deviation of a variable normalized to its mean. This measure is
used to give a sense of how large the standard deviation is. (CRV=(std/mean)×100%).
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The CRV was selected because it describes the spread of a data distribution. But if the
distribution is not gaussian, it does not contain information about the maximum and
the minimum of the data values. Therefore, we also report the maximum of the data
variation as the ratio of the maximum SAR values divided by the minimum SAR values
in dB. (dB=10log(SARmax/SARmin))
2.3 Results
We first report the calculated SAR variations per evaluation method (field-sensor and
Talairach). Next we assessed the psSAR10g variation. Finally the results of the uncertainty
analyses are demonstrated. The SAR values were normalized to the net input power (1
W).
2.3.1 SAR variation using the field-sensor method
Left plots in Figure 2.3 and Figure 2.4 show the mean and std of the averaged SAR
in the inserted field sensors (i.e. 1cm3 of brain tissue in 16 different locations); The right
plots in the figures show the calculated variation for each field sensor. The figures indicate
that variations are higher at 1900 MHz than at 835 MHz. They also show that the SAR
values in the brain regions are lower at 1900 MHz compared to 835 MHz which is due
to smaller penetration depth at 1900 MHz than 835 MHz. The average and the min-max
range of the variations per exposure setup are shown in Figure 2.5. Table 2.3 summarizes
Figure 2.3 and Figure 2.4 by providing the amount and location of maximum detected
variation.
Table 2.3: The maximum variation in the averaged SAR in different sensors.
Exposure configuration dBmax
∗ Sensor of dBmax CRVmax ∗ Sensor of CRVmax
835 MHz-cheek 16.0 1 78.1 9
1900 MHz-cheek 15.6 16 107.32 16
835 MHz-tilted 15.4 10 93.0 1
1900 MHz-tilted 16.4 16 104.8 16
∗
dBmax= maximum of the dB values. CRVmax= maximum of the CRV values.
2.3.2 SAR variation using the Talairach method
Figure 2.5 shows the amount of the SAR variation based on the levels defined in the
Talairach hierarchy. In order to compare the results of our two post-processing methods,
we also included the SAR variations based on the field-sensor method in this figure.
Here, the average of the CRV or the dB values over all regions in the brain and the
max-min range of the variations between defined regions at each level are indicated. For
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Figure 2.3: Left: Mean and standard deviation of the averaged SAR in the inserted
field sensors at 835 MHz; Right: Calculated variations in terms of ratio of
(max/min) and CRV (std/mean).
example the bar with square marker at 1900 MHz-cheek configuration indicates that the
variations between heads range from 8.20 dB, in ’left Cerebrum’ region, to 13.63 dB in
’right Brainstem’ region and the average of variations over all brain regions is 10.76 dB
(the brain regions in the hemispherical level are left cerebellum, right cerebellum, left
cerebrum, right cerebrum, medulla, left brain stem and right brain stem). The differences
between the levels in Figure 2.5 and Table 2.4 show that as expected, the amount of
SAR variation depends on the size of averaging volume and as shown, by increasing the
size (from lobe to tissue levels), the variation will decrease. Figure 2.5 indicates that the
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Figure 2.4: Left: Mean and standard deviation of the averaged SAR in the inserted
field sensors at 1900 MHz; Right: Calculated variations in terms of ratio
of (max/min) and CRV (std/mean).
results of our two methods are consistent and the average of variations is higher (around
4.9 dB in ’cheek’ position and 4.7 dB in ’tilted’ position) at 1900 MHz than at 835 MHz.
The mean of variation in SAR, based on the Talairach method, over all brain regions is
around 5 dB for 835 MHz and 10 dB for 1900 MHz. The maximum variation of SAR
between the brain regions is in the medulla, which belongs to the lobe type level of
Talairach hierarchy, and reaches an order of magnitude of 15.8 dB. Table 2.4 shows the
amount of dBmax and also the assigned labels of the region with the largest dB, per
exposure setup and per Talairach level.
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Figure 2.5: Variation of the average SAR between the head models based on our two
post-processing methods: Field-sensor (blue) and Talairach (red), in terms
of a) ratio of (max/min) and b) CRV (std/mean). The markers show the
mean of variation over all brain regions and the error bars show the max-
min range per exposure setup.
2.3.3 Variation of peak spatial average SAR
Figure 2.6 presents the mean and std of psSAR10g values in the head and brain for the 20
head models. Table 2.5 summarizes the calculated variation and indicates that the psSAR
variation is around 4 dB in the head and can reach up to 7 dB in brain tissue at 1900MHz
and in the cheek position. Variations in the spatial locations of psSAR values in the heads
and brains are calculated as the distances between the furthermost peak-points. Table 2.5
shows that the maximum spatial variation in the location of psSAR is around 8 cm in the
heads of various models.
2.3.4 Numerical uncertainty
To evaluate the expanded uncertainty U of the numerical modeling and simulation settings
with 95% confidence, we assessed the influence of various modeling parameters on the
simulation results for psSAR10g in the head. Table 2.2 shows that, for non-uniform grid
2.4 Discussion 27
Table 2.4: The amount and the label of the region where the maximum deviation in
SAR per Talairach level was registered.
Label of region with dBmax , level of dBmax
Level 835 MHz-cheek 835 MHz-tilted 1900 MHz-cheek 1900 MHz-tilted
Lobe Frontal-Temporal Frontal-Temporal Medulla Medulla
Space, 10.45 Space, 11.67 15.84 13.59
Hemispherical Right Cerebellum ∗ Right Brainstem Right Brainstem
5.46 7.85 13.63 12.10
Tissue Cerebro-Spinal White Matter Cerebro-Spinal Cerebro-Spinal
Fluid, 3.81 3.84 Fluid, 11.65 Fluid, 9.87
∗non-labeled regions. No VOT label was assigned to these brain regions.
Table 2.5: Variations of psSAR10g in the brain and head between the head models.
835 MHz-cheek 835 MHz-tilted 1900 MHz-cheek 1900 MHz-tilted
Head Brain Head Brain Head Brain Head Brain
CRV 21.31 25.28 34.98 18.97 26.31 35.34 26.73 34.60
max/min (dB) 4.37 3.49 4.88 2.78 4.00 7.21 4.17 6.14
spatial var.(mm) 69.74 49.08 43.41 60.89 84.43 60.93 30.95 56.06
discretization and by assuming normal distribution and uncorrelated combination, U is
1.26 dB for psSAR10g.
2.4 Discussion
In this study, we investigated the variation of local power absorption in the brain caused
by morphological changes in 20 head models. We used two different evaluation methods
and found that the variation of the averaged SAR in specific brain regions can reach up
to 15.8 dB in the medulla region (Talairach method) and up to 16.4 dB in a 1cm3 cube
(field-sensor method). This large variation is due to the fact that, in different heads, the
distance from the source (mobile phone antenna) to that specific brain region is different,
i.e. although the equivalent regions are in relatively similar positions in all brains, their
absolute distances from the source differ.
From Figure 2.3 and Figure 2.4, one may think that large variation in low exposure area
is less of interest. We note, however, that the main objective of this study is to investigate
the influence of morphological changes on the RF dose in the area where the brain tumor
would preferentially occur. Therefore, it is highly relevant to mention that three of the
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Figure 2.6: Mean and standard deviation of the psSAR10g in the brain and head.
four sensors with the maximum variations (Table 2.3 sensors 1, 9 and 10) are located in
the areas in which brain tumors are most frequently found, i.e. the frontal and temporal
lobes. In addition, the calculated variations in high exposure area (over sensors 5, 8, 12
and 14) are also large with maximum of 16.3 dB which is related to sensor 12 and 1900
MHz-tilted configuration.
We also found that the variations in morphology lead to larger differences in SAR at a
higher frequency. The smaller penetration depth at a higher frequency leads to a lower
absorption in the deeper regions of the brain, and consequently to less uniform exposure of
the brain. Therefore, a certain variation in the distance between the region of interest and
the source causes a greater SAR-variation in a less uniform field than the same deviation
does in a uniform field.
Comparison of the results in Figure 2.5 and Table 2.4 shows that an increase in the size
of the averaging volume (from sensors in the field-sensor method to tissue level in the
Talairach method), will reduce the variation.
To compare our two evaluation methods, we would say that the accuracy of the brain-
registration in the field-sensor method was 2.4 mm in terms of the averaged mean surface
distance (MSD). This means that the position of a specific sensor in the brains varies
by an average of 2.4 mm (error falls within image resolution). However, the results may
be underestimated by this method because only parts of the brain are included. On the
other hand, while the Talairach method is more complete and covers the whole brain, the
definition of Talairach landmarks in our study, as explained in section 2.2.4, might induce
some uncertainty in mapping the brain positions into the Talairach atlas and vice versa.
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From the fact that the results of the both methods are similar (maximum SAR variation:
15.8 vs. 16.4 dB), we conclude that our results are robust and the conclusion is justified.
To investigate the influence of simulation parameters, the numerical uncertainty evalu-
ation was also included. The results show that the psSAR10g variation caused by modeling
parameters is equal to 1.26 dB, which is very small relative to the magnitude of the SAR
variations obtained. Therefore, our results are also robust to simulation parameters.
The secondary end-point was to assess the variation in psSAR10g caused by morphological
changes in the heads. The head psSAR10g variation was 4 dB, which is slightly larger than
the variation of psSAR10g reported in previous studies (3 dB) that used several head mod-
els and configurations13,60,105. This increase may be due to the fact that we used a larger
number of head models and consequently more variant head morphologies. Furthermore,
these studies either had a limited number of head models13 or they used scaled models,
which lead to large uncertainties in the prediction of local brain exposure60,105. To the
best of our knowledge, the current is based on the highest number of different anatomical
head models in dosimetric studies involving mobile phone exposure.
To be able to evaluate the potential impact of our results on the Interphone study, we must
apply the same restrictions as the Interphone and therefore apply the same matching vari-
ables between case and controls, i.e. age (within 5 years), sex, and region of residence11.
If we restrict our population to these conditions, the SAR variations will decrease in the
sensors with an average of 5 dB. The maximum variation of 16.4 dB among 20 individuals
therefore decreases to 11.8 dB among 4 males (e.g. models 12, 13, 17, 19) in the same
field sensor.
Finally we should mention that our study had a number of limitations. First, the sample
of 20 selected head models is not representative for the general population, however our
results indicate that head morphology can have a high impact on the local RF dose in the
brain. This is important for the cases investigated in the Interphone study. Furthermore,
as observed in Table 2.1, we conclude that the head characteristics of our samples are in
line with human variation.
Second, as mentioned previously, the brain tissues were not segmented in this study, i.e.
the brain was considered as a homogeneous tissue. We expect that the segmentation of
brain tissues will add to the local dose variation between individuals. In this case, the SAR
variation would not only be governed by morphological differences but also by the large
differences in the dielectric properties. To verify this, we performed additional simulations
for three of our models (patients number 12, 13 and 14) for whom MR-scans were also
available. The results confirmed our expectation and showed that the SAR variations,
when taking the average over the field sensors, increased from 3 dB between CT-models
(homogeneous brain) to 4 dB between MR-models (heterogeneous brain); The impact of
full brain segmentation is the topic of our ongoing study.
Third, the phone model which was used in this study was generic and simplistic. However,
as mentioned in section 2.2.2, it is the model developed for the same purpose (i.e. com-
parison of the SAM to 14 anatomical head models) by60. The authors mentioned that the
phone model was agreed upon with members of the MMF (Mobile Manufacturers Forum)
as the standard model for comparative studies. By using the same phone model we are
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able to compare our results to that study which helps for understanding the variation
found in both studies and to have an accumulation of knowledge. In addition, the impact
of various phone models has already been shown by40.
In summary, if we consider a total uncertainty budget for dosimetry of mobile phone
radiation in head and brain, we find the following sources of uncertainty in literature
(Table 2.6):
1. Mobile phone model: the variation in brain region-specific exposure is typically around
5 dB, but can reach up to 18 dB40
2. The relative position of the mobile phone and head: the maximum variation of psSAR10g
in the head was around 4 dB at 900 MHz and 6.6 dB at 1900 MHz over 80 different
relative phone positions39
3. Age-dependent changes in the dielectric tissue parameters: the differences in psSAR10g
due to the age-dependent changes of the tissue dielectric are approximately 0.5 dB
at 900 and 1.5 dB in 1800 MHz13.
4. Pinna compression: the reduced distance caused by pinna compression led to an in-
crease of approximately 2dB in psSAR10g if the maximum exposure is located at the
pinna14.
Here, we introduce a new source of uncertainty which is:
5. Individual morphological properties: the variation in brain region-specific exposure is
typically around 5 dB for 835 MHz and 10 dB for 1900 MHz but, according to
Table 2.6: Comparison of uncertainty sources in mobile phone dosimetry.
Source Paper studied parameter Max var.
(dB)
1 Phone type Gosselin et al. 2011 Region-specific SAR 18
2 Phone position Ghanmi et al. 2011 psSAR10g 6.6
3 Age-dependent Christ et al. 2010 psSAR10g 1.5
dielectric properties
4 Pinna compression Christ et al. 2010 psSAR10g 2
5 Head morphology This study psSAR10g 4
Region-specific SAR 16.4
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Talairach tool, can reach up to 15.8 dB and, according to field-sensor method, up
to 16.4 dB. Maximum variation of psSAR10g is around 4 dB in the head and 7dB in
the brain.
Table 2.6 summarizes the uncertainty sources and their impacts on mobile phone studies.
2.5 Conclusions
Differences in head morphological properties caused up to 16.4 dB variation in the av-
eraged SAR in specific brain regions between 20 head models (Sample: 13 males and 7
females aged between 36-76 years) and 11.8 dB limited to the Interphone’s restrictions
(sub-sample: 4 males aged between 65-69 years). Thus, estimation of local RF averaged
SAR in the brain on the basis of generic phantoms and not on the real morphology is
subject to a considerable variability and therefore head morphology should be taken into
account for estimation of cumulative RF dose in the brain. The extent of this variability
depends on the exposure setup (mobile phone frequency and position) and on the size
and position of the brain region in question.

CHAPTER 3
Association of acute adverse effects with high local SAR induced in
the brain from prolonged RF head and neck hyperthermia
This chapter is based on:
F Adibzadeh, RF Verhaart, GM Verduijn, V Fortunati, Z Rijnen, M Franckena, GC van Rhoon and MM
Paulides. Association of acute adverse effects with high local SAR induced in the brain from prolonged
RF head and neck hyperthermia.
Phys Med Biol, Vol. 60, pp. 995-1006, 2015.
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Abstract
Purpose: To provide an adequate level of protection for humans from
exposure to radio-frequency (RF) electromagnetic fields (EMF) and to assure
that any adverse health effect is avoided, the basic restrictions in terms of
specific energy absorption rate (SAR) were prescribed by IEEE and ICNIRP.
An example of a therapeutic application of non-ionizing EMF is hyperthermia
(HT), in which intense RF energy is focused at a target region. Deep HT in
the head and neck (H&N) region involves inducing energy at 434 MHz for
60 minutes on target. Still, stray exposure of the brain is considerable but to
date only very limited side-effects were observed. The objective of this study
is to investigate the stringency of the current basic restrictions by relating
the induced EM dose in the brain of patients treated with deep head and neck
(H&N) HT to the scored acute health effects. Materials and methods:
Hereto, we performed a simulation study to calculate the induced peak 10 g
spatial-averaged SAR (psSAR10g) in the brains of 16 selected H&N patients
who received the highest SAR exposure in the brain, i.e. who had the minimum
brain-target distance and received high forwarded power during treatment.
Results: The results show that the maximum induced SAR in the brain of
the patients can exceed the current basic restrictions (IEEE and ICNIRP)
on psSAR10g for occupational environments by 14 times. Conclusions:
Even considering the high local SAR in the brain, evaluation of acute effects
by the common toxicity criteria (CTC) scores revealed no indication of a
serious acute neurological effect. In addition, this study provides pioneering
quantitative human data on the association between maximum brain SAR
level and acute adverse effects when brains are exposed to prolonged RF EMF.
3.1 Introduction
The application of non-ionizing electromagnetic field (EMF) in the radiofrequency (RF)
range of the spectrum is not only limited to telecommunication systems such as radio and
television broadcasting, mobile phone and WiFi, but also many biomedical applications
use RF EMF for diagnosis and therapy such as magnetic resonance imaging (MRI) and
hyperthermia (HT). During HT cancer treatment, the tumor temperature is increased
by 3− 8 ◦C, which has shown to enhance treatment outcome without increasing toxicity
when added to radiotherapy (RT) and/or chemotherapy (ChT)59,96,104. Besides depositing
energy at the target region, stray radiation leads to unwanted exposure of other normal
tissues (Figure 3.1). Deep hyperthermia in the head and neck region, especially for target
regions in the nasopharynx and paranasal sinuses, involves heating very closely to the
brain. Hence, there is a relevant risk of HT-related acute effects in the brains. In this
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Figure 3.1: Picture of the HYPERcollar system (left). Example of the SAR distribu-
tion inside the head (right), the red line indicates the target region.
study, we investigated the association of relatively high localized SAR in the patients
brain with the acute health effects observed after H&N HT treatments.
To protect against excessive temperature rises from localized exposure in any part of the
body, basic restrictions have been developed by a number of international and national
organizations, including the ANSI, IEEE and ICNIRP. Based on the current common
criteria for human exposure to electromagnetic fields55,57, exposure should not result in
peak spatial average SAR (psSAR) that exceeds 10 W/kg as averaged over any 10 g of
tissue (psSAR10g). This level applies to exposure of persons in occupational environments,
i.e. trained adults under controlled conditions. The exposure limit has been reduced by a
factor of 5 for public environments, i.e. individuals of all ages and various health statuses,
leading to a psSAR10g limit of 2 W/kg. The exposure limits incorporate safety factors that
account for uncertainties in the data and that provide a large margin of safety for other
limiting conditions such as high ambient temperature, humidity, or level of physical activ-
ity. The safety factors, which are generally selected arbitrarily, are conservative so that
exposures that exceed the basic restrictions are not necessarily harmful. All guidelines for
limiting exposure are based on established adverse health consequences induced by RF
exposure. To date, at RF frequencies above 100 KHz, only acute thermal effects have been
observed but current findings are almost entirely data obtained by animal experiments
(IEEE 2005). Therefore, human data is of vital importance for assessment of the induced
health hazards that are the basis of the development of safe RF exposure restrictions.
The main objective of our study was to evaluate the association of acute adverse effects
with HT-induced dose in the brain from prolonged (60 minutes) RF HT in patients in
order to investigate stringency of the current basic restrictions. To achieve this goal, we
firstly assessed the maximum induced psSAR in the brain of 16 patients during H&N
HT treatment and compared the results with the common basic restrictions. Anatomical
models of these 16 patients were generated from tissue segmentation based on CT-scans.
Segmenting white matter regions on CT-scans is not possible and the total brain is seg-
mented as one structure. Therefore, we also assessed the influence of brain segmentation
detail on the induced psSAR in the brain. Finally, we assessed the common toxicity criteria
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(CTC) data reported for the treated patients to evaluate the association of HT-induced
SAR in the brain with acute health effects.
3.2 Methods
3.2.1 Head and neck hyperthermia
Hyperthermia treatments of 60 minutes each were given after radiotherapy once or twice
a week at intervals of at least 72 h85,96. Hyperthermia was delivered using the HYPER-
collar78,79. The HYPERcollar is a phased array applicator that consists of twelve electro-
magnetic patch antennas operating at 434 MHz. To enhance the efficiency of the energy
coupling into the patient and to cool the skin, the space between the HYPERcollar anten-
nas and patient is filled with a waterbolus (Figure 3.1). The amplitudes and phases of the
sinusoidal signals applied at all 12 antennas are independently controlled. To maximize
power delivery at the target region the signals (powers and phase-differences) and patient
positioning are optimized using hyperthermia treatment planning (HTP). HTP is based
on electromagnetic simulations using 3D patient-specific models for optimization and tis-
sue dose assessment80,85. To account for differences in patients and thermal properties,
the antenna signals are adapted during clinical treatment based on an online steering
procedure85.
3.2.2 Anatomical phantoms
Computational simulations using anatomically detailed models of adults and children have
been used in several studies to predict electromagnetic exposure of humans for various
exposure applications and environments6,13,21,47,53,75,102,105. In the current study, we used
detailed 3D models of patients to assess the EM dose in the brain during H&N HT. These
patient models are generated by segmenting tissue regions using Computed Tomography
(CT) scans, which encompass the whole head and part of the shoulders. Seven different
tissue types (internal air, bone, fat, muscle, spinal cord, brain and lung) were segmented
manually99. We assessed the induced psSAR10g in the brain of 16 patients selected from
45 patients treated with HT that far (September 2014). The CT-based models of these
16 patients were selected, as they received the highest forwarded power during treat-
ment and had the minimum target-brain distance. Tumors were primarily located in the
nasopharynx and oropharynx (nasal and oral cavity).
Note that it is impossible to segment detailed brain structures on CT-scans, so the brain
is modelled as one homogeneous mass with grey matter properties. Therefore, SAR assess-
ment is based on a rough model of the brain. To evaluate the influence of detailed brain
segmentation, we compared the psSAR10g values between CT-based (homogeneous) and
MR-based (detailed) brain models of 12 patients. Among these 12 patients, of which MR
scans were also available, only the first one was treated with HT. Fortunately this case
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Figure 3.2: homogeneous (CT-based) versus detailed (MR-based) brain model, as used
in this study to investigate the influence of brain segmentation details.
turned out to be the worst-case in terms of SAR exposure in our study, i.e. the patient
with the highest SAR in the brain.
3.2.3 Influence of brain segmentation details
To evaluate the influence of brain tissue distribution on the induced SAR in the brain, we
calculated the psSAR10g using homogeneous (CT-based) and detailed (MR-based) brain
models and assessed the differences. Mean and standard deviation of these differences give
the systematic and random errors caused by modelling the brain as a homogeneous tissue
(as used in HTP) instead of using detailed segmentation.
A state of art method15,17 has been applied for the automatic segmentation of the brain
tissues, i.e. cerebro-spinal fluid (CSF), grey matter (GM), and white matter (WM) from
T1-weighted (T1w) and T2-weighted (T2w) MR images. This method consists of a super-
vised segmentation using the k-nearest neighbor (kNN) classifier. The training of such a
classifier is automatically obtained using atlas registration. The detailed segmented brain
was registered to the CT model using optimized settings29. Figure 3.2 shows the brain
tissues in both the homogeneous and the detailed model.
3.2.4 EM-modeling
EM computations were performed using the finite difference time domain (FDTD) solver
of SEMCAD X ∗. A uniform gridsize of 1.3 mm, a 15 mm padding and medium strength
∗SEMCAD X EM Simulation, version 14.8.4 (www.semcad.com).
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UPML boundaries were chosen. Antennas were excited by a sinusoidal signal of 15 periods,
using optimized phase and amplitude settings that correspond to the maximum forwar-
ded power during HT treatment. In this study, we calculated the maximum psSAR over
treatment. Dielectric tissue properties were assigned to each tissue according to the ITIS
material parameter database48. The value of psSAR10g in shape of a cube, as calculated
in SEMCAD X, was used for SAR dosimetry.
3.2.5 Validation of EM-modeling results
The predicted SAR distributions that are induced by the HYPERcollar were evaluated
in a cylindrical muscle phantom by comparing the measurements to simulations77,78. We
demonstrated that the measured SAR distributions were well predicted by simulations.
However, in clinical applications most of the applicator inefficiency, as defined in this
study, stems from the waterbolus shape variations over patients (anatomical phantoms).
To assess this impact we calibrated the SAR predictions by deriving a scalar ‘applic-
ator efficiency’. Hereto we used invasive temperature measurements obtained from clin-
ical treatments for those 14 H&N patients of which temperature data from interstitially
placed probes was obtained. The power-off method87,103 was applied to reconstruct the
SAR values from temperature decay measurements, as described in86. In addition, we
developed an accurate probe reconstruction procedure to obtain the simulated SAR cor-
responding to the measurement of each temperature probe86,100. Next, the applicator
efficiency factor was optimized such that the error between reconstructed and simulated
SAR values per patient and per waterbolus-shape was minimized. Finally, we computed
the mean and distribution of the differences between measurements and simulations, on
a patient-specific and treatment-specific basis, to obtain the best assessment of the mean
applicator efficiency and its variation in the clinic.
3.2.6 Sensitivity analysis
We performed a sensitivity analysis to determine the changes in psSAR10g that result
from changes in EM simulation and patient modeling parameters. Model discretization
(gridsize) and dielectric tissue properties were reported as the most significant influence
quantities (i.q.)6,41,99. The effect of these parameters was determined based on a previous
study using 7 patient models, balanced per tumor site99. The uncertainty is quantified in
|∆psSAR10g| and the individual uncertainty was obtained by taking the square-root of
the sum of squares of the mean value over 7 patients. In the current study, the uncertainty
due to detailed brain segmentation and applicator efficiency were also investigated.
The effect of the gridsize variation was investigated by changing the gridsize from 1 to
5 mm with stepsize of 0.5 mm, with an addition of gridsize 1.3 mm. For each gridsize
|∆psSAR10g| was determined by using the HTP with gridsize = 1 mm as reference.
The variation in tissue properties (σeff , r and ρ) was determined for the brain tissue.
For each tissue property, three different HTPs were generated, i.e. using average and ±
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one standard deviation of the literature value. |∆psSAR10g| was determined by using the
HTP for the average literature value as reference.
The variation in psSAR values between homogeneous and detailed models of the brain
was calculated for 12 patients, as mentioned in section 3.2.2. Mean and standard deviation
of this variation give the systematic error and the uncertainty of modeling the brain as a
homogeneous tissue, respectively.
We derived the uncertainty due to the applicator efficiency by optimizing the applicator
efficiency factor which, as defined in this paper, is a scalar that captures not only the losses
in the conductors and antennas, but also all effects of non modelled radiation losses in the
waterbolus (section 3.2.5). Note that the impact of the waterbolus on superficial levels
is very inhomogeneous but deep in the brain this approximation becomes valid. psSAR
values were calculated for each applicator efficiency factor, i.e. using mean and standard
deviation of the optimized value. |∆psSAR10g| was determined by using the average value
as reference.
The individual standard uncertainty (ui) of the gridsize, dielectric properties, detailed
segmentation and applicator efficiency was obtained by determining the confidence inter-
val from plus to minus one standard deviation. The combined standard uncertainty (uc)
was obtained by taking the square-root of the sum of squares of the individual uncer-
tainties. The coverage factor (k) of 2 was used to obtain the expanded uncertainty (U)
with 95% confidence interval. The uncertainties were determined using a normal (N) or
rectangular (R) probability distribution for each i.q.: N for dielectric properties according
to6, R for gridsize according to41 and R for applicator efficiency and brain segmentation
details because this distribution provides the most conservative estimate when minimum
knowledge is available.
3.2.7 HT-related acute health effect
To investigate the possibility of serious HT-related acute health effects, we studied the
Common Toxicity Criteria (CTC) scores of the selected patients. CTC is a standardized
classification of adverse effects used in cancer therapy evaluation, developed by the Na-
tional Cancer Institute †. Any treatment-related adverse event experienced by a patient
is graded by clinicians using the specific terms in the CTC. Table 3.1 shows the general
definition of the grades 0 to 5 with their unique clinical descriptions of severity. Grading is
not modified based on patient’s condition at baseline. Baseline data, including laboratory
data and signs and symptoms, should be collected at treatment entry. If a given adverse
event is experienced more than once in a treatment session, only the most severe event
is graded. Adverse events not included in the CTC (v3.0) should be reported under the
‘Other ’adverse events and graded according to the general grade definition.
All HT patients are questioned by physicians before a treatment starts (baseline) and
after each treatment session, leading to CTC scores for toxicity and pain. In addition, at
†http://ctep.cancer.gov/protocolDevelopment/electronic application/ctc.htm.
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Table 3.1: CTC Grades definition
Grade definition
0 No adverse event or within normal limits
1 Mild adverse event; asymptomatic or mild symptoms;
clinical or diagnostic observations only; intervention not indicated.
2 Moderate adverse event; minimal, local or noninvasive intervention indicated;
limiting age-appropriate instrumental ADL∗.
3 Severe or medically significant but not immediately life-threatening;
hospitalization or prolongation of hospitalization indicated; disabling;
limiting self care ADL∗∗.
4 Life-threatening consequences; urgent intervention indicated.
5 Death related to adverse event
Activities of Daily Living (ADL)
∗Instrumental ADL refer to preparing meals, shopping for groceries or clothes, using the
telephone, managing money, etc.
∗∗Self care ADL refer to bathing, dressing and undressing, feeding self, using the toilet,
taking medications, and not bedridden.
the beginning of each HT session, patients are asked to describe how the treatment has
affected them (active open questioning).
3.3 Results
3.3.1 Influence of brain segmentation details
Figure 3.3 shows the difference in psSAR10g when the brain is modeled as homogeneous
GM (model 1) and GM+WM+CSF (model 2). This figure indicates that the induced
psSAR10g in the brain decreases in detailed models (model 2) compared to homogeneous
models (model 1) by 21.5%, averaged over the models. Inclusion of CSF in the tissue
list for calculation of psSAR, increases the psSAR10g value by 15.1% averaged over the
models, compared to the homogeneous model. Hence, the predicted dose in the detailed
model is particularly dependent on the presence of CSF.
3.3.2 Applicator efficiency
We obtained the applicator efficiency factor, which minimized the difference between
measured and simulated SAR values, per treatment session and per patient. The optimized
efficiency factor ranges from 0.29 to 0.71 with mean and standard deviation of 0.40 and
0.14, respectively, averaged over all waterbolus-shapes.
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Figure 3.3: Variations of the psSAR10g in the brain between homogeneous and detailed
brain models across 12 patients. The results are normalized to the net input
power (1 W).
3.3.3 Sensitivity analysis
Table 3.2 summarizes the impact of various modeling parameters on the obtained results.
The uncorrelated standard combined uncertainty uc is 11.7% and the expanded uncer-
tainty U is 23.4% for psSAR10g. Note that the impact of applicator efficiency variation
overrules the other uncertainties studied.
3.3.4 HT-related acute health effect
Table 3.3 contains the CTC grades of the observed acute toxicity occurred during all HT
treatment sessions for the selected patients. No grade 4 or 5 toxicities were observed and
the three CTC grade 3 incidents were all subcutaneous burns that healed without any
further medical attention. Other observed toxicities did not exceed CTC grade 2 in any
of the patients.
3.3.5 Induced psSAR in the brain versus scored acute effects
Figure 3.4 shows the scatter plot of maximum obtained psSAR10g in the brain during H&N
HT treatments versus maximum CTC grade. The maximum CTC grade, scored for each
patient is related to the maximum induced psSAR in the brain providing a dose-response
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Table 3.2: Evaluation of the standard combined uncertainty (uc) and the expanded
uncertainty (U) as measured with |∆psSAR10g|. Div. is the division factor
to obtain the standard uncertainty (std. unc.) and k is the coverage factor
for the confidence interval. The sensitivity coefficients ci equals one for all
influence quantities.
SAR unc.[%] SAR std. unc.[%]
|∆psSAR10g| prob. dist. Div |∆psSAR10g|
Gridsize 3.7 R
√
3 2.1
Dielectric tissue properties
(a) σeff 3.4 N 1 3.4
(b) r 2.8 N 1 2.8
(c) ρ 3.3 N 1 3.3
Brain segmentation details 10.9 R
√
3 6.3
Applicator efficiency 13.9 R
√
3 8.0
uc 11.7
U (k=2) 23.4
picture. Note that data in Table 3.3 and Figure 3.4 are different. Table 3.3 includes all
incidents of acute effects whereas Figure 3.4 demonstrates the maximum scored CTC grade
per patient. For instance, Table 3.3 includes 3 incidents of CTC grade 3 but 2 incidents
were for the same patient therefore, the number of CTC grade 3 in Figure 3.4 is 2. The
cross markers (Figure 3.4a) display the CNS-related adverse effects (headache, pain in eye,
dizziness, nausea, vomiting, pns. motory and pns. sensory) versus psSAR10g in the brain
and the circle markers (Figure 3.4b) show the maximum CTC-grades for the remaining
effects (subcut skin, fat, muscle and bone) versus the psSAR10g in the corresponding tissue
types. The psSAR values are corrected for the systematic error calculated in section 3.3.1
(brain segmentation details) and 3.2 (applicator efficiency). Since patients are treated
under supervision of medical physicians, the results are only compared to the ICNIRP and
IEEE basic restrictions for occupational environment (controlled environment). Figure 3.4
shows that the basic restriction on psSAR10g is exceeded for all patients.
3.4 Discussion
Published experimental data on adverse RF effects in humans is very scarce, but is of
great potential value to health and standards agencies for developing safe limits of RF
exposure. At present, the basic restrictions rely almost entirely on much less satisfactory
animal experimental data which is more difficult to interpret, contributing to a rather
unsystematic approach in setting the safety factors of RF exposure limits. In this study,
we addressed concerns about temperature increases in the human brains from a prolonged
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Table 3.3: Observed acute toxicity for the selected HT patients. Note that the number
of incidents were counted, i.e. not just one incident per patient, so every
treatment session always led to one score.
Nr of patients: 16
Total Nr of HT sessions:74
CTC-grade 0 1 2 3 4 5
Pns motory 74 0 0 0 0 0
Pns sensory 71 1 2 0 0 0
Headache 73 1 0 0 0 0
Pain in Eye 73 1 0 0 0 0
C
N
S
-r
el
at
ed
Dizziness 73 1 0 0 0 0
Nausea∗ 71 2 1 0 0 0
Vomiting∗ 72 2 0 0 0 0
Subcut skin 70 2 0 2 0 0
Subcut fat 72 0 2 0 0 0
Subcut muscle 72 0 2 0 0 0
S
u
b
cu
t
b
u
rn
s
Subcut bone 69 1 3 1 0 0
∗Nausea and vomiting may stem from reactions in the CNS but also from many other
causes. In this study they are considered as CNS-related acute effects.
(60 minutes) and relatively high localized exposure during head and neck HT and the as-
sociation of such exposure with acute health effects. The results show that the maximum
induced psSAR10g in the brain of the selected patients exceed the basic restrictions
55,57
for occupational environments up to 14 times. The results obtained can even be regarded
as conservative estimates since we used the applicator efficiency factor reconstructed from
temperature decay measurements, i.e. 0.4. This factor may be affected by measurements
adjacent to external or internal skin, leading to overestimates of tissue cooling. In addi-
tion, this factor is lower than the efficiency obtained experimentally using a cylindrical
phantom and a symmetrical waterbolus shape, i.e. 0.7. Hence the SAR values may have
been 75% higher. In future, we aim to investigate the association between SAR and func-
tional brain changes using our new HYPERcollar3D95, which has been used for three
patients, that has a much more predictable waterbolus shape leading to improved SAR
predictions.
The condition of the patients at baseline, during and after each treatment section were
checked by the physicians using the CTC guidelines. These data indicates that there is
no evidence of serious (CTC grade 3 and more) acute HT-related neurological toxicity
for any of the selected patients (Figure 3.4 and Table 3.3). Moreover, in multimodality
therapies such as radiotherapy combined with hyperthermia, adverse events may also be
caused by the multimodality combination: in this study we allocated all of them to only
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Figure 3.4: Scatter plot of the maximum CTC grade vs the maximum induced
psSAR10g for the selected patients during H&N HT treatment. (a)
The maximum CTC-grades for CNS-related adverse effects versus the
psSAR10g in the brain. (b) The maximum CTC-grades for the subcu-
taneous burns versus the psSAR10g in the corresponding tissue types. The
results are compared to the occupational basic restrictions (green dashed
line). The psSAR10g values are corrected for the systematic errors, due to
homogeneous brain modeling and applicator efficiency. Errorbars indicate
the calculated 95% confidence interval of the uncertainty.
the EMF exposure during hypethermia.
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We also investigated the influence of the brain segmentation details in a 3D patient-specific
model and found that the detailed segmentation reduces the psSAR10g in the brain tis-
sues (WM and GM) compared to homogeneous brain model by 21.5%, averaged over the
patients. The decrease in SAR for the detailed model is consistent with the fact that the
CSF surrounding the brain is highly conductive, i.e. its electrical conductivity is five and
three times larger than that of WM and GM respectively. Therefore, CSF absorbs a large
portion of the incident EM power leading to less power absorption in the brain tissues
(GM and WM). Hence, more detailed segmentation affects local tissue dose predictions.
A sensitivity study showed an expanded uncertainty of 23.4% in psSAR10g due to vari-
ations in simulation settings and patient modelling parameters (Table 3.2). However,
even taking into account these uncertainties, the results are still valid, i.e. even for the
lower uncertainty bound the basic restrictions are exceeded for all patients.
Finally, we note that, based on this study, we do not claim that exposure of the brain
to the RF EMF during deep H&N HT has no influence on human health and biology.
However, based on the current CTC data, we observed no indication that any serious
neurological acute effect is induced at SAR levels above the assumed thresholds.
3.5 Conclusions
This study provides pioneering quantitative human data on the association between the
maximum brain SAR level and acute effects when brains are exposed to RF EMF. Such
information is pivotal input for establishing dedicated psSAR10g restrictions to avoid ad-
verse effects in occupational and public EMF exposure conditions. Evaluation of acute
adverse effects from prolonged exposure to deep RF head and neck hyperthermia reveals
that although the brain was exposed up to 14 times the common basic restriction on
psSAR10g, there is no indication of any induced serious neurological adverse effect. This
study provides initial data that enables to determine the basic restrictions based on the
functional change that is to be prevented and the level of safety to ensure prevention. Ex-
panding upon this data, a library of associations between exposure level and effect-level
can be created for continuously tailoring the basic restrictions.

CHAPTER 4
Absence of acute ocular damage in humans after prolonged
exposure to intense RF EMF
This chapter is based on:
F Adibzadeh, GC van Rhoon, GM Verduijn, NC Naus-Postema and MM Paulides. Absence of acute
ocular damage in humans after prolonged exposure to intense RF EMF.
Phys Med Biol, Vol. 61, pp. 488-504, 2016.
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Abstract
Purpose: The eye is considered to be a critical organ when determining
safety standards for radio-frequency (RF) radiation. Experimental data
obtained with animals showed that RF heating of the eye over a specific
threshold particularly can induce cataracts. During hyperthermia treatment
of cancer in the head and neck, the eyes receive a considerable RF dose due
to stray radiation of the prolonged (60 minutes) and intense exposure at 434
MHz of this region. In the current study, we verified the exposure guidelines
for humans by determining the association between the electromagnetic and
thermal dose in the eyes with the reported ocular effects. Materials and
methods: We performed a simulation study to retrospectively assess the
specific absorption rate (SAR) and temperature increase in the eyes for 16
selected patients (encompassing 74 total treatment sessions) whose treatment
involved high power delivery as well as a minimal distance from the tumor site
to the eye. Results: Our results show that the basic restrictions on the peak
10 g spatial-averaged SAR (10 W/kg) and peak tissue temperature increase
(1 ◦C) are exceeded by up to 10.4 and 4.6 fold, on average, and by at least 6.2
and 1.8 fold when considering the lower limit of the 95% confidence interval.
Conclusions: Evaluation of the acute effects according to patients feedback
(all patients), the common toxicity criteria scores (all patients) and an
ophthalmology investigation (one patient with the highest exposure) revealed
no indication of any serious acute ocular effect, even though the eyes were
exposed to high electromagnetic fields, leading to a high thermal dose. We
also found that, although there is a strong correlation (R2=0.88) between the
predicted induced SAR and temperature in the eye, remaining uncertainties
in temperature-SAR relationship are large. Given this large uncertainty
(129%) compared to the uncertainty of 3D temperature simulations (61%),
we recommend to use temperature simulations as dosimetric measure in
electromagnetic exposure risk assessments.
4.1 Introduction
To avoid any adverse health effect from exposure to radio frequency (RF) electromagnetic
fields (EMF), basic restrictions for the SAR levels in humans are developed by a number
of international and national organizations, including the ANSI, IEEE and ICNIRP. The
restrictions are based on keeping the body temperature increase under 1 ◦C. Based on
the current common criteria for human exposure to electromagnetic fields55,57, exposure
should not result in peak spatial average SAR (psSAR) that exceeds 10 W/kg as averaged
over any 10 g of tissue (psSAR10g). This level applies to exposure of persons in occupational
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environments, i.e. trained adults under controlled conditions. These guidelines incorporate
large safety factors to assure that any effect, reversible and non-reversible is avoided. To
date, the only known adverse effect for radiofrequency (RF) exposure above 100 KHz are
acute temperature dependent effects. Heat tolerance varies between tissues and the eyes
have been regarded as one of the most thermo-sensitive tissue in the ICNIRP guidelines.
A number of reversible and non-reversible ocular effects by heat have been reported. In a
recent overview of heat-induced normal tissue effects by Yarmolenko et al., they concluded
that a CEM43◦C of only 21.3 minutes leads to adverse effects in cornea of rabbits110. Us-
ing the CEM43◦C definition19 and the duration of steady-state temperatures during a
hyperthermia treatment, i.e. 60 minutes, the thermal dose can be rearranged to 42.2 ◦C.
Elder specifically reviewed the effects of RF waves on eye structures25. He summarized
that the non-reversible effects reported are cataracts, corneal lesions, retinal effects, and
changes in vascular permeability. However, the majority of studies were about cataracts
and, furthermore, basing a threshold on the other effects is hampered by conflicting data
and the absence of functional changes. Following this data, guidelines for exposure to RF
exposure are based on avoiding the induction of cataracts.
The two most cited studies with respect to cataracts are by Guy and Kramar et al45,63.
They showed that the minimum SAR required to produce a lens cataract in rabbits is
between 100 and 150 W/kg for up to 100 minutes in the vitreous body of the eye45.
The results also indicated that the temperature behind the lens must exceed 41 ◦C for
production of posterior lens opacities. By numerical simulations they established that
the temperature rise was caused by a peak SAR in the eye, right behind the lens. How-
ever, when temperatures remained below 41 ◦C by means of reduction of the whole-body
temperature, the same SAR levels did not produce any opacity in the lenses of exposed
animals63. These findings suggest that it is really the temperature that induces the catar-
acts. The same group also showed that equal, and higher, exposure levels do not lead to
cataracts formation in rhesus monkeys, which was allocated to different energy absorption
patterns in the eyes of monkeys from those in rabbits70. Furthermore, they deduced that
43 ◦C was required to form cataracts in the lenses of monkeys.
With respect to therapeutic applications, Bollemeijer et al reported the effect of RF-
induced heat on the eye using their 2450 MHz stripline applicator7,65. Healthy eyes of
nine rabbits were heated to a fixed temperature in the range of 42− 46 ◦C for 30 minutes
as predicted using a thermal model. Histology based analysis 12 days after the expos-
ure revealed a transition at 44 − 45 ◦C, above which local necrosis, pigment disruption
and local cataract developed. These observations were confirmed in vivo by comparative
fluorescein angiography and anterior segment fluorophotometry that showed fluorescein
leakage of the iris vessels. In65, in agreement with the experiments, no cataract was ob-
served upon heating the lens of a patient to 44 ◦C for one hour. Note that this study only
assessed acute effects and cataracts can appear up to one year after treatment. Hence,
these data do not exclude the existence of a lower threshold for long term effects.
These studies show that extrapolation of the results from animals to humans may not
be valid. Therefore, human data is of vital importance for assessment of the association
between exposure and induced health hazards as foundation for the development of im-
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proved RF exposure restrictions. In the current study, we investigated the association of
relatively high induced SAR and temperature in the human’s eye with the acute health
effects observed after head and neck (H&N) hyperthermia (HT) cancer treatments. In
H&N HT, the tumor temperature is elevated towards 39− 44 ◦C by applying focused RF
energy to tumors in the head and neck region78. Besides depositing energy at the target
region, stray radiation leads to unwanted exposure of other normal tissues (Figure 4.1),
especially for target regions in the nasopharynx, nasal cavity and paranasal sinuses, which
are adjacent to the eyes. Hence, there is a relevant risk of HT-related acute effects in the
eyes.
In the previous chapter, we showed that there is no indication for association of neurolo-
gical acute effects and the high excessive local SAR in the brain from exposure to H&N
HT. In the current study, we verified the validity of this finding for ocular effects and also
expand the data to peak temperature rise estimation to determine if the thermal dose,
i.e. peak temperature over a prolonged duration of exposure, induced by such high local
SAR values leads to acute thermal effects.
The main objective of our study was to evaluate if there exist an association of acute
ocular damage with HT-induced psSAR and temperature rise in the eye from prolonged
(60 minutes) exposure to RF HT. In order to determine the suitability of psSAR10g as an
appropriate metric for safety guidelines, we verified the correlation of induced psSAR10g
to peak temperature increase. To achieve these goals, we firstly calculated the maximum
induced psSAR and the peak temperature increase in the eye of 16 patients during H&N
HT treatment and compared the results with the common basic restrictions and the eye
thermal threshold. Secondly, in order to assess and understand the reliability of the results,
we performed an extensive sensitivity analysis. Finally, to investigate the possibility of
HT-related ocular damage, we studied the common toxicity criteria (CTC) data reported
for the treated patients and the results of opthalmology tests for one patient.
4.2 Methods
4.2.1 Head and neck hyperthermia
Hyperthermia treatments of 60 minutes each were given after radiotherapy once or twice
a week depending on the radiotherapy radiation schedule85,96. Hyperthermia in the head
and neck region was delivered using the HYPERcollar applicator78,79. The HYPERcollar
is a ring-shape phased-array applicator that consists of twelve electromagnetic patch an-
tennas symmetrically distributed on 2 antenna rings and operating at 434 MHz. To cool
the skin and to enhance transfer of the electromagnetic waves into the patient, the space
between the HYPERcollar antennas and patient is filled with a waterbolus (WB). For
all patients, patient-specific hyperthermia treatment planning (HTP) is done prior to the
first treatment to determine the optimal position of the applicator as well as the optimal
settings of phase and amplitude per individual channel. In our current HTP, electromag-
netic simulations are used to predict the energy deposition, i.e. SAR, in the patient80,85.
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(a)
(b) (c)
Figure 4.1: Picture of the HYPERcollar system in clinical use (a). Example of the
predicted SAR (b) and Temperature (c) distribution on the planning CT.
To account for differences in patients and thermal properties, the antenna signals are ad-
apted during clinical treatment based on an online complaint-adaptive steering strategy85.
It is worth mentioning that the patients are not under anesthesia during treatment. Hence,
the patients have their full thermophysiological response and pain sensation.
4.2.2 Anatomical phantoms
3D models of 16 patients were selected from a group of in total 49 patients treated with
H&N HT until January 2015. In these patients, the SAR was assumed to be the highest in
the eye since they had the smallest eye-target distance and received the highest averaged
forwarded power during treatment. The patient models were generated by automatically
segmenting ten different tissue types (internal air, bone, fat, muscle, spinal cord, brain,
sclera, vitreous humor, lens and optical nerve) on Computed Tomography (CT) scans99.
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Table 4.1: dielectric and thermal properties of tissues at 434 MHz.
Tissue r σ(S m
−1) ρ(kg m−3) c(W m−1 Q(W/kg) k(J kg−1 ω(ml min−1
◦C−1) ◦C−1) kg−1)
Internal air 1 0 1.2 - - - -
Bone 13.1 0.09 1908 1313 0.15 0.32 10.0
Fat 11.6 0.08 911 2348 0.51 0.5a 255.0a
Muscle 56.9 0.81 1090 3421 0.96 0.4a 442.8a
Tumour 59.0 0.89 1050 3950 - 1.5a 848.0a
Spinal cord 35.0 0.46 1075 3630 2.48 0.41b 1815.5c
Brain 56.8 0.75 1045 3696 15.5 0.44b 8644.6c
Sclera 57.4 1.01 1032 4200 5.89 0.47b 4303.4c
Vitreous humor 69.0 1.53 1005 4047 - 0.48b -
Lens 37.3 0.38 1076 3133 - 0.35b -
Optical nerve 35.0 0.46 1075 3613 2.48 0.40b 1815.4c
Note: Q is the metabolic heat generation rate. aDerived from patient-group optimization
of thermal tissue properties based on invasively measured temperatures101.
Value in48 scaled 0.8-foldb or 11.3-foldc to account for thermal stress.
4.2.3 EM modeling
EM computations were performed using the finite difference time domain (FDTD) solver
of SEMCAD X ∗. A uniform gridsize of 1.3 mm, a 40 mm padding and medium strength
UPML boundaries were chosen. Antennas were excited by a sinusoidal signal of 15 periods,
using optimized phase and amplitude settings that correspond to the maximum forwarded
power during HT treatment. Dielectric tissue properties were assigned to each tissue
according to the ITIS material parameter database48 (Table 4.1). We used the applicator
efficiency (ηHY PERcollar) of 0.4 for the HYPERcollar system which was calculated by using
the interstitial temperature measurements obtained from clinical treatments2.
In the current study, we calculated the maximum psSAR10g, in shape of a cube, over
treatment for SAR dosimetry.
4.2.4 Thermal modeling
The SAR-induced temperature rise was calculated for the selected patients using transi-
ent temperature simulations in SEMCAD X according to Pennes bioheat equation. We
applied a mix of convective and Neumann (fixed flux) boundary conditions at the tissue-
surrounding air, tissue waterbolus and tissue-internal air interfaces. The initial temper-
∗SEMCAD X EM Simulation, version 14.8.4 (www.semcad.com).
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ature in the tissues was set to 37 ◦C while the temperature of the surrounding air and
the waterbolus was set to 20 ◦C as measured during hyperthermia treatments. To apply
actual treatment power steering in the temperature simulation, user-defined sources were
created for which the treatment phase and amplitude settings were applied to each an-
tenna and the combined EM field was used to compute the SAR. The scaling factor of
the source was the applicator efficiency factor (0.4). The assigned thermal tissue prop-
erties are shown in Table 4.1. We took thermal tissue properties under thermal stress
into account. The assigned properties for muscle, fat and tumour were derived from101, in
which thermal conductivity (k) and perfusion (ω) values for these tissues were optimized
based on invasive thermometry in ten H&N patients. Since the k and ω of the brain and
eye tissues under thermal stress are unknown, we mimicked this variation by applying the
same variation as the variation in muscle tissue. Going from a baseline value (no thermal
stress)48 to the optimized value under thermal stress101 an increase of 0.8 fold (k) and
11.3 fold (ω) was applied (Table 4.1). This scaling for eye and brain tissues is reasonable
because our current study shows that high local EM and thermal doses are induced in
the eyes and our previous study on the brain exposure2 shows very high psSAR levels (up
to 140 W/kg). Note that the values of (k) and (ω) were optimized by applying the same
applicator and applicator efficiency as used in this study (ηHY PERcollar=0.4).
Besides the absolute temperature, thermal tissue damage is also determined by the ex-
posure time30,31,97,110. Therefore, the temperature increase averaged over the steady-state
duration (60 minutes) of HT treatment at the location of the maximum achieved temper-
ature (Tss(@Tmax)) was used for thermal dosimetry:
Tss(@Tmax) = Tss(r = rTmax), r = (x, y, z), (4.1)
4.2.5 Sensitivity analysis
We investigated the influence of the modeling parameters and simulation settings on
the induced psSAR10g and Tss(@Tmax) in the eyes for the patient with the worst case
exposure of the eye, i.e. with the highest SAR and temperature in the eye. The investigated
influence quantities and their studied range of variations are indicated in Tables 4.2
and 4.3. For each influence quantity, three different values were studied, i.e. a HTP
was performed using average and ± one standard deviation of the literature value. The
individual standard uncertainty (ui) was quantified in |∆psSAR10g| and |∆Tss(@Tmax)|
and obtained by determining the confidence interval from plus to minus one standard
deviation, using the average literature value as reference. The square-root of the sum of
squares to the ui values was applied to obtain the combined standard uncertainty (uc).
The uncertainties were determined based on the assumption that the applied variations
can be described by Gaussian probability functions. A coverage factor k of 2 was used to
obtain the expanded uncertainty U within the 95% confidence interval.
For the standard uncertainty of the source power, we used the uncorrelated combined
standard uncertainty of the induced SAR from Table 4.2.
An important source of uncertainty is the WB connection with the eyes during treatment
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Table 4.2: EM modeling parameters and their uncertainties as used in the sensitivity
analysis. r is the relative dielectric permittivity, σ is the effective elec-
tric conductivity, ρ is the volume density of mass. The uncorrelated stand-
ard uncertainty (uc) and the expanded uncertainty (U) is measured with
|∆psSAR10g| in Eye-tissues. k is the coverage factor for the confidence in-
terval.
Parameter value studied range |∆psSAR10g|(ui)[%]
Applicator efficiency 0.4a 14%a 13.9
WB-eye connection - No - full contact 5.5
Discretization 1.3 (mm) 1-1.3 (mm) 2.3
Eye-tissue properties
(a) r Table 1 15%
b 3.6
(b) σ Table 1 25%b 12.7
(c) ρ Table 1 6%b 3.2
uc (Source power) 20.3
U (k=2) 40.6
aDerived from2. bDerived from the ITIS Foundation tissue database48.
which varies from the simulated model due to WB shape variations. Because the WB
shape is difficult to define and varies considerably between and during treatments, we
studied the worst case scenario by comparing the results of simulations with full versus
no WB-eye connection.
The effect of the spatial discretization was determined by simulating the grid step 1 mm
as reference, assuming that ∆grid → 0 leads to the most accurate result. Decreasing the
gridsize increases the computation time dramatically so we selected the reference of 1 mm
as a balance between computational time and accuracy.
Tissue properties in patients deviate from literature values, e.g. due to age-dependency,
post-mortem changes, and measurement uncertainty. In the current study, we derived
the uncertainty of all tissue properties from literature48. Under thermal stress the blood
perfusion of the tissues increases. Lang et al. developed a model to describe temperature
dependant blood perfusion variation68. They used special functions for fat, muscle and
tumour which follow in temperature range of 37-44 ◦C behaviors introduced by Song
et al. 90 . Hence, for blood perfusion, for which we combined the variation at baseline and
variation due to temperature increase, i.e. the range of variation for blood perfusion was
estimated as 38% which is combination of the uncertainty at baseline (35%) and the
uncertainty due to maximum deviation from the optimized temperature (39 ◦C) in101 as
estimated using the Lang model (16%).
The uncertainty in heat transfer coefficients and blood parameters were derived from10
and5.
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Table 4.3: Thermal modeling parameters and their studied range of variation as used
in the sensitivity analysis. c is the specific heat capacity , k is the thermal
conductivity, ρ is the volume density of mass, ω is the volumetric blood
perfusion rate, ρb blood density, cb blood-specific heat, Tb blood temperat-
ure, hair−skin and hbolus−skin and hinternalair−lung heat transfer coefficients,
Tair surrounding air temperature, Tbolus bolus temperature, Tinternalair in-
ternal air temperature. The uncorrelated standard uncertainty (uc) and the
expanded uncertainty (U) is measured with |∆Tincr,max| in Eye-tissues. k is
the coverage factor for the confidence interval.
Parameter value studied range |∆Tss(@Tmax)|(ui)[%]
Source power SAR profile (W/kg) ±20.3% 21.3
WB-eye connection - No - full contact 3.7
Discretization 2 (mm) 1 - 2 (mm) 0.9
Eye-tissue properties
(a) c Table 1 ±13%a 2.3
(b) ρ Table 1 ±6%a 1.6
(c) k Table 1 14%a 13.4
(d) ω Table 1 38%b 9.9
Boundaries
(a) hair−skin 20 (W m−2) ±30% d <0.1
(b) hbolus−skin 82 (W m−2) ±30% d <0.1
(c) hinternalair−lung 50 (W m−2) ±30% d <0.1
(d) Tair 20 (
◦C) 1◦C c <0.1
(e) Tbolus 20 (
◦C) 1◦C c <0.1
(f) Tinternalair 37 (
◦C) 1◦C c 0.1
Blood parameters
(a) Heat capacity (cb.ρb) 5.1
ρb 1050 (kg m
−3) ±2%c
cb 3617 (W m
−1 ◦C−1) ±8%c
(b) Tb 37
◦C 0.5◦C c 11.8
uc 30.3
U (k=2) 60.7
aDerived from the ITIS Foundation tissue database48.bDerived from101. cDerived from10.
dDerived from5.
4.2.6 Correlation between the induced SAR and temperature
To determine the appropriate metric for protecting against RF heating effects, we verified
the correlation of high SAR levels with high-temperature levels. To simplify the correlation
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analysis, we computed the least-squares regression coefficient (R2) of the linear fits of
Tss(@Tmax) as a function of psSAR10g.
4.2.7 HT-related acute ocular effect
Treatment toxicities are scored by the grading system of the National Cancer Institute †
to uniformly score the toxic acute and subacute effects of cancer therapy. The Common
Toxicity Criteria (CTC) scores are concerned with the physiologic and functional end-
points, many of which are transitory and reversible. A grading (severity) scale is provided
for each adverse effect term (Table 4.4).
All HT patients in our clinic are questioned by physicians before a treatment starts
(baseline) and after each treatment session, leading to CTC scores for toxicity and pain.
In addition, at the beginning of each HT session, patients are asked to describe how the
treatment has affected them in the time between treatment sessions (active open ques-
tioning). Therefore, we receive patients’ feedbacks on any health problem. In the current
study, we evaluated the possibility of serious HT-related acute ocular damage by studying
the CTC scores of the selected patients. Any treatment-related adverse event experienced
by a patient was graded between 0 to 5 with a conservative attention for eye related
toxicity using the specific terms in the CTC standard. In addition, for one patient with
the worst case exposure, i.e. the highest psSAR10g in the eye, functional changes were in-
vestigated by performing a regular ophthalmology test prior to, during and after the HT
treatment (immediately and up to 18 months after). This patient had four HT sessions
in two weeks and was treated for long duration (70-80 minutes each) with high power
(average of the forwarded power during treatment was 400 W).
4.3 Results
4.3.1 Sensitivity of EM and thermal modeling
Tables 4.2 and 4.3 summarize the impact of various EM and thermal modeling para-
meters on the calculated psSAR10g and Tss(@Tmax). The total expanded uncertainty of
the psSAR10g predictions (95% confidence interval) is 40.6%, which is mainly due to the
uncertainties of applicator efficiency and electrical conductivity of the eye tissues. Con-
sequently, the critical factor in thermal modeling is the uncertainty in the SAR profile.
This factor as well as the variations in eye thermal conductivity and blood parameters
are the dominant factors in creating the expanded uncertainty of 60.7% in temperature
predictions.
†http://ctep.cancer.gov/protocolDevelopment/electronic application/ctc.htm.
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Table 4.4: Observed acute toxicity for the selected HT patients with a conservative
attention for eye related toxicity. Note that the number of incidents were
counted, i.e. not just one incident per patient, so every treatment session
always led to one CTC-score.
Nr of patients: 16
Total Nr of HT sessions:74
Grade 0 1 2 3 4 5
Pain in Eye 69 5 0 0 0 0
Pns motory 74 0 0 0 0 0
Pns sensory 73 1 1 0 0 0
Headache 70 3 1 0 0 0
Dizziness 73 1 0 0 0 0
ge
n
er
al
C
N
S
Nausea 71 2 1 0 0 0
Vomiting 72 2 0 0 0 0
Subcut skin 70 2 0 2 0 0
Subcut fat 72 0 2 0 0 0
Subcut muscle 72 0 2 0 0 0
S
u
b
cu
t
b
u
rn
s
Subcut bone 69 1 3 1 0 0
Grade 0: No adverse event or within normal limits.
Grade 1: Mild adverse event; intervention not indicated.
Grade 2: Moderate adverse event; minimal, local or noninvasive intervention indicated.
Grade 3: Severe or medically significant but not immediately life-threatening.
Grade 4: Life-threatening or disabling adverse event; urgent intervention indicated.
Grade 5: Death related to adverse event.
4.3.2 HT-related acute ocular effect
Table 4.4 contains the CTC grades of the observed acute toxicity occurred during all
HT treatment sessions for the selected patients. It shows that from 74 HT sessions for
the selected patients, no grade 4 or 5 toxicities were observed and the three CTC grade 3
incidents were all subcutaneous burns that healed without any further medical attention.
Two incidents of CTC grade 2 were observed regarding nausea and headache which were
not associated with the eyes. Hence, eye related toxicities did not exceed CTC grade 1 in
any of the patients. In addition, there was no self reported vision loss.
Pre-treatment and post-treatment ophthalmology testing of the patient with the worst
case exposure showed that lenses were clear and hence no indication of cataracts was
observed. In addition, no feedback on the development of cataract in the long term was
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received for any treated patient.
4.3.3 Induced psSAR and temperature rise in the eyes during
H&N HT treatment
Figures 4.2 and 4.3 show the scatter plots of the maximum calculated psSAR10g and
Tss(@Tmax) in the eyes during H&N HT treatments versus maximum CTC grade for
non-burns adverse effects per patient. Square markers represent the scored grades for
pain in the eye. Since general CNS-related adverse effects (pns. motory and pns. sensory,
headache, dizziness, nausea, vomiting) may stem from eye problems, we also showed the
scatter plot of the induced doses versus general CNS responses using circle markers. Note
that Figures 4.2 and 4.3 demonstrate only the maximum scored CTC grade per patient
whereas Table 4.4 includes grades of all incidents of acute effects for all HT treatment
sessions. Since patients are treated under supervision of medical physicians, the results are
only compared to the ICNIRP and IEEE basic restrictions for occupational environment
(10 W/kg). Figure 4.2 shows that the maximum psSAR10g in the eyes reaches up to 104
W/kg on average and 62 W/kg if considering lower limit of the 95% confidence interval,
i.e. the induced EM dose in the eyes exceeds the basic restrictions by at least up to 6.2
times. For the lower uncertainty bound, the basic restrictions are exceeded for 12 of 16
patients.
The calculated temperature increases are compared to the basic restriction of 1◦C on
peak tissue temperature increase (green dashed-line) and also to the functional threshold
of 5.2◦C based on110 (red dotted-line). Figure 4.3 shows that the maximum Tss(@Tmax)
on average is 4.2◦C and at the lower limit of the 95% confidence interval is 1.8◦C. We
also found that the predicted peak temperatures were located in vitreous-humor of the
eyes. In addition the maximum estimated CEM43◦C thermal dose in the lens is 0.56
minutes which is 38 times lower than the functional threshold of 21.3 minutes above
which thermal damage has been observed in other studies. Comparison of figure 4.2 and
4.3 demonstrates that exposure exceeding the basic restrictions on psSAR10g may not lead
to temperatures exceeding the functional and even basic thresholds, e.g. from 12 patients
with excessive eye exposure, 10 cases did not exceed the functional thermal threshold,
with 95% confidence.
4.3.4 Correlation between the induced SAR and temperature
Figure 4.4 indicates a strong and positive correlation between Tss(@Tmax) and psSAR10g
for the selected patients, which is confirmed by a high correlation coefficient (R2= 0.88).
However, there is a very large uncertainty in the residual error of the linear fit, i.e. 95%
confidence interval for the residuals is 129%.
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Figure 4.2: Scatter plot of the maximum induced psSAR10g in the eyes of the selected
patients during H&N HT treatment vs the maximum CTC grade for pain
in eye (a) and general CNS effects (b). The markers display the adverse ef-
fects versus psSAR10g in the eyes and the errorbars indicate the calculated
95% confidence interval of the uncertainty. The markers are demonstrated
in 5 groups based on their CTC grades. The results are compared to the
occupational basic restrictions.
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Figure 4.3: Scatter plot of the Tss(@Tmax) in the eyes of the selected patients during
H&N HT treatment vs the maximum CTC grade for pain in eye (a) and
general CNS effects (b). The markers display the adverse effects versus
Tss(@Tmax) in the eyes and the errorbars indicate the calculated 95% con-
fidence interval of the uncertainty. The markers are demonstrated in 5
groups based on their CTC grades. The results are compared to the basic
(green dashed-line) and functional (red dotted-line) thermal threshold of
the eye.
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Figure 4.4: Correlation of Tss(@Tmax) to psSAR10g for the selected patients. The linear
fit parameters are represented by the slope (afit=∆T/∆SAR) and the
goodness of the fit (R2).
4.4 Discussion
The current guidelines of ICNIRP and IEEE aim at limiting excessive localized tissue
heating by providing restrictions on psSAR10g. The eyes are particularly vulnerable to
RF heating because of the relative lack of available blood flow to dissipate the excess heat
load. Therefore, the sensitivity of the visual organ to RF electromagnetic induced heat
was amongst the main concerns when developing the RF safety standards. Clearly, the
motivation was to prevent formation of lens opacity: cataracts. However, the current safety
guidelines are based on experimental data obtained from animals. In the current study,
we analyzed the association of high EM (psSAR10g) and thermal (Tss(@Tmax)) dose in the
human eye with acute ocular effects. Since the thermal tissue damage is determined by
induced temperature and also exposure time, we calculated the thermal dose by averaging
the peak temperature increase over 60 minutes of steady state duration in HT treatment.
To evaluate the association of HT-induced SAR and temperature increase in the eyes
with acute ocular effects, we studied the common toxicity criteria (CTC) data reported
for the treated patients. The condition of the patients at baseline, during and after each
treatment section were checked by the physicians using the CTC guidelines. Moreover, the
worst case patient, with the highest SAR and temperature in the eye, was examined by
regular ophthalmology investigations prior, during and up to 18 months after HT treat-
ment. The results show that the maximum predicted induced psSAR10g and Tss(@Tmax)
in the eyes of the 16 selected patients during H&N HT treatment exceed the basic restric-
tions55,57 for occupational environments on psSAR10g and peak tissue temperature by up
to 10.4 and 4.6 times on average. Considering the uncertainties in the model parameters,
these values are 6.2 and 1.8 times at the lower limit of the 95% confidence interval (k = 2)
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(Figure 4.2, Figure 4.3). Analysis of the CTC-scored database indicates that there is no
evidence of serious (CTC grade 3 and more) acute HT-related ocular toxicity for any of
the selected patients (Figures 4.2, 4.3 and Table 4.4). Pre-treatment and post-treatment
ophthalmology testing also showed that there is no indication for cataracts. Therefore,
based on the current CTC data, patients report and opthalmology result, we observed
no indication for induction of cataracts or any serious acute ocular effect at SAR and
temperature levels above the assumed thresholds. Note that the calculated temperature
increase can exceed the functional level of 42.2◦C110 for 2/16 patients if considering the
higher bound of uncertainty (Figure 4.3) and reach up to 7.4◦C in vitreous humor tissue.
To assess the influence of WB cooling effect on our results, we have calculated the tem-
perature increase in the eye exposed to the same SAR but without connection to the WB,
i.e. under normal environmental conditions where the common guidelines are intended to
be applied that were modelled using a convective thermal boundary to air. The result
shows that in the absence of WB, the Tss(@Tmax) increases by 7.6% which is within the
expanded standard uncertainty. Given this small impact, we still expect that the mean
temperature is affected just slightly and that the confidence interval is appropriate. Hence,
our results are also valid under normal environmental conditions and not only when the
eyes are subject to the WB.
Major problems in temperature assessment are the incorporation of the effect of blood
flow and a realistic and detailed implementation of the anatomy with the correct thermal
properties for the individual tissues. In this study, we used detailed segmented anatomical
model of the eye based on the CT-scans of the patients and the assigned thermal proper-
ties of the tissues incorporate the strong thermoregulatory response of H&N tissues under
thermal stress. However, a number of limitations may have affected our results. Firstly,
we used the Pennes bioheat equation, which uses a homogeneous heat-sink term and does
not incorporate vasculature. Many studies attempted to model more complicated mech-
anisms, such as the impact of discrete vasculature and metabolism effects8,26,50–52. Flyckt
constructed a DIscrete VAsculature (DIVA) model of the eye and showed that the Pennes
bioheat model serves as an appropriate thermal model for predicting low temperature
rises. At higher temperature rises, we expect that the DIVA model leads to a lower sclera
temperature due to the increase in blood perfusion under thermal stress. Therefore our
results will be valid even by inclusion of vasculature because, based on our simulations,
the peak temperature rises were located in vitreous humor body of the eyes. Secondly, we
did not take the influence of vitreous humor convection into account. Since the calculated
temperature for vitreous humor is higher than sclera, we expect that consideration of
convection leads to a higher sclera temperature and a lower vitreous humor temperature.
Karampatzakis and Samaras 61 showed that the most notable effect of consideration of
convective heat transfer of eye fluid is that the coolest area of the cornea moves at a point
of 2 mm inferior to its geometric centre. Hence, the effect of humor flow on the amount
of the induced temperature was negligible. Finally, we note that, as acute toxicity in this
study is scored based on patient responses to physicians, i.e. subjective complaint scores,
it does not rule out sub-clinical adverse effect in the eyes. Therefore, further research is
required to study more subtle functional changes, e.g. by performing ophthalmological
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follow-ups for more patients.
To verify the appropriateness of the psSAR10g as a metric for protecting against RF heat-
ing effects, we assessed the correlation of Tss(@Tmax) to psSAR10g. The results of linear
regression show that they are strongly and positively correlated (R2=0.88). However, a
same SAR level may result in different temperature increases in different eye sizes and
anatomies. The uncertainty of predictions using the fit exceeds that of the actual simu-
lated temperatures (129% vs 61%), which advocates using 3D temperature simulations in
stead of SAR values. Hence, the best metric for setting the safety guidelines remains the
peak temperature increase over a specific duration. In addition, the uncertainty in thermal
modeling can be reduced by improving the individual uncertainties, i.e. specifically the
EM source by reducing setup errors and improving treatment reproducibility of the HY-
PERcollar applicator, like in our novel HYPERcollar3D applicator81,95. By this step, in
future, we will be able to provide even better estimates of the temperature distribution.
4.5 Conclusions
Experimental data on adverse RF heating effects in humans is of great potential value for
health and standards agencies to develop safe limits of RF exposure. The current study
provides initial data on association between exposure level and functional changes in the
human eyes, which is considered as a highly sensitive tissue in setting RF safety guidelines
and regulations. We investigated the peak local SAR and temperature increase in the eyes
from prolonged exposure to deep RF head and neck hyperthermia. Our data shows that,
exposure exceeding the basic restrictions on psSAR10g by at least up to 6.2 folds leads
to peak temperature increase of at least up to 1.8◦C in the eye averaged over 60 minutes
steady state duration of the treatment. No indication for cataracts or any serious acute
ocular damage was observed upon this exposure. Therefore, our data confirms that the
current guidelines provide adequate protection against excessive temperature increase in
the eyes from exposure to RF EMF. The correlation study further shows that the uncer-
tainty in modeling the relationship between temperature increase and psSAR10g is higher
than the uncertainty in 3D temperature modeling. Hence in our view, future guidelines
require restrictions on peak temperature increase for specific duration of exposure instead
of restrictions on psSAR10g.

CHAPTER 5
SAR thresholds for electromagnetic exposure using functional
thermal dose limits
This chapter is based on:
F Adibzadeh, MM Paulides and GC van Rhoon. SAR thresholds for electromagnetic exposure using
functional thermal dose limits.
Submitted to Int J Hyperthermia, 2016.
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Abstract
Purpose: To quantify the magnitude of safety factor included in the
current basic restrictions on specific absorption rate (SAR) in tissues for
different exposure scenarios based on thermal damage threshold. The cur-
rent basic restrictions incorporate large safety factors which are generally
conservative. The magnitude of safety margin for various radiofrequency
localized exposure scenarios is unknown. This shortcoming becomes more
critical for medical applications where the safety guidelines are required to
be relaxed. Materials and methods: Hereto, for each exposure scenario,
we used the lowest thermal dose (TD) required to induce acute local tissue
damage reported in literature, calculated the corresponding TD-functional
SAR limits (SARTDFL) and related these limits to the basic restrictions,
thereby estimating the respective safety factor. Results: The margin of safety
factor in the current basic restrictions on psSAR10g is large, i.e. up to 31.2
depending on exposure duration and hotspot-size. Conclusions: Our analysis
can be converted into clear indications of SARTDFL for different exposure
scenarios, e.g. 150 W/kg for hyperthermia applications (60 min exposure
and a target size of 4 cm in diameter). The benefit of a quantitative safety
factor is that it facilitates decision making on how much the responsible
investigator can increase local SAR with an acceptable risk of thermal damage.
5.1 Introduction
To avoid excessive heating in tissues, ICNIRP and IEEE organizations have defined
guidelines for limiting human exposure to electromagnetic fields (EMF)55,57. Based on
these guidelines for a radiofrequency (RF) range of 100 kHz−3 GHz, exposure should not
result in peak spatial average SAR (psSAR) that exceeds 10 W/kg as averaged over any 10
g of tissues (psSAR10g). This level applies to exposure of persons in occupational environ-
ments, i.e. trained adults under controlled conditions. The foundations of the guidelines
are biological RF dose effect studies using rodent and non-human primate models. To
account for uncertainties in the data and to provide a large margin of safety for other
limiting conditions such as high ambient temperature, humidity, or level of physical activ-
ity and also to increase confidence that the standard is below the levels at which adverse
effects could occur, the local SAR threshold is lowered by an arbitrary safety factor: at
least a safety factor of 10 and probably considerably more if the remarkable tolerance in
human studies is accepted as generally valid. Therefore, these guidelines introduced safety
factors to assure that any effect, both reversible and irreversible, is avoided. However, in
some applications, such as medical imaging or therapy, taking more risk is permissible
if this provides a better diagnosis or therapeutic effect. For instance, in hyperthermia
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(HT) cancer therapy and magnetic resonance imaging (MRI), the goal is to balance the
probability of cure, or the correct diagnosis, versus the probability of side-effects. Fur-
thermore, this exposure is only permitted for a specific duration and under control of
medical doctors. In this respect, we recently performed dose-effect relations studies and
showed that exceeding the basic restrictions (i.e. 10 W/kg) by up to at least 14 (brain2)
and 10 (eyes3) times during hyperthermia treatment in head and neck (H&N) region,
showed no indication for any serious acute effect for any of the treated patients. Clearly,
medical applications are very different than the domestic applications with respect to the
safety standard guidelines. This difference is reflected in the suitability of a much smaller
safety factor. However, the relevance of the magnitude of the safety factor for a certain
localized exposure scenario is unknown and might be restrictive for the functionality of
the exposure purpose. Especially, in HT and MRI there is a need to more exactly identify
the incorporated safety factor and to tailor EM exposure thresholds by expanding the
safety limits.
The main objective of the current study was to assess the safety factor incorporated in
the current ICNIRP and IEEE basic restrictions for various localized exposure scenarios.
To achieve this goal, we first translated the functional thermal dose (TD) required to
induce acute local tissue damage reported in literature (Table 5.1) into corresponding
TD-based functional SAR limits (SARTDFL). The ratio between these SARTDFL values
and the basic restrictions, leads to the respective safety factor. Hereto, we calculated the
SARTDFL for localized exposure, i.e. calculated in a hotspot-mimicking sphere, inside tis-
sues based on the Pennes bioheat equation (PBE) (Figure 5.1). Secondly, we performed a
sensitivity study to assess the changes in the calculated SARTDFL due to exposure para-
meters. Thirdly, we evaluated our results by comparing the SARTDFL to SAR levels in
realistic clinical situations. Finally, we proposed a simple procedure to decide what SAR
level would be acceptable under a certain exposure scenario.
5.2 Methods
In the current study, we calculated the lowest SARTDFL values necessary to induce heating
up to Tthresh at the centre of the hotspot-representing sphere (focus) within a 37
◦C me-
dium (Figure 5.1). Tthresh is the corresponding temperature to the lowest thermal dose per
tissue type, in units of cumulative equivalent minutes at 43◦C (CEM43◦C), that results in
thermal tissue damage, derived from our previous study97 (Table 5.1). The SARTDFL was
calculated using the partial differential equations (PDE) toolbox in MATLAB to solve
the PBE. The PDE toolbox provides functions for solving partial differential equations
in 2D, 3D and time using finite element analysis. Secondly, we assessed the sensitivity
of SARTDFL due to changes in the focus diameter (as a result of changes in exposure
frequency), exposure duration and thermal tissue properties. We calculated the SARTDFL
for focus diameters of 20, 15, 10, 5, 2, 1 and 0.5 cm using various databases containing
thermal baseline and thermo-regulated tissue properties49,68,72,91. We compared the value
of SARTDFL among various available tissues in table 5.1, considering the worst case in
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Figure 5.1: Picture of a modelled hotspot-mimicking sphere (focus) inside a tissue at
37(◦C). Example of SARTDFL necessary to induce Tthresh (◦C) heating,
as shown in Table 5.1, at the centre of the sphere.
Table 5.1: Translation of the lowest tissue specific CEM43◦C doses that result in
thermal tissue damage in large animals and humans, to the correspond-
ing temperature for exposure durations of 60, 30, 15 and 5 minutes.
Tissue CEM43◦C ∗ (min) Tthresh(◦C)
t=60 (min) t=30 (min) t=15 (min) t=5 (min)
Brain 7.5 41.5 42.0 42.5 43.6
Spinal Cord 30.0 42.5 43.0 44.0 45.6
Peripheral Nerve 45.5 42.8 43.6 44.6 46.2
Skin 288.0 45.3 46.3 47.3 48.8
Esophagus 120.0 44.0 45.0 46.0 47.6
Liver 9.9 41.7 42.2 42.7 44.0
Kidney 70.0 43.2 44.2 45.2 46.8
Bladder 90.5 43.6 44.6 45.6 47.2
Rectum 30.0 42.5 43.0 44.0 45.6
Prostate 30.0 42.5 43.0 44.0 45.6
Muscle 60.0 43.0 44.0 45.0 46.6
Fat 240.0 45.0 46.0 47.0 48.6
∗ Derived from97.
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which the focus volume is uniformly heated. By this simplification, the conduction term
in PBE can be set to zero and hence the PBE can be solved analytically. To evaluate the
influence of exposure duration on the results, we compared the SARTDFL for exposure
duration of 60, 30, 15 and 5 minutes in spheres of 20, 5, 2 and 0.5 cm diameters in muscle
using McIntosh (resting-condition) and Erasmus MC (thermal stress) databases for tissue
properties. Finally, we evaluated our results by comparing the calculated SARTDFL values
in the current study with simulated SAR using SEMCAD X (v.14.8.4, SPEAG, Zurich,
Switzerland) inside a realistic anatomical model under exposure of RF EMF from head
and neck (H&N) hyperthermia treatment.
5.2.1 CEM43◦C thermal dose
The CEM43◦C dose model expresses the thermal load on living tissues by estimating the
equivalent induced thermal stress in minutes at 43◦C. We translated the reported tissue
specific CEM43◦C thresholds to Tthresh based on the CEM43◦C definition assuming a
constant temperature over the duration of exposure:
CEM43◦C =
n∑
i=1
tiR
(43−T ) (5.1)
Where CEM43◦C is the cumulative number of equivalent minutes at 43◦C, ti is the i-th
time interval, R is related to the temperature dependence of the rate of cell death (R(T<43
◦C)=1/4, R(T>43 ◦C)=1/2) and T is the average temperature during time interval ti.
5.2.2 Pennes bioheat equation
Pennes bioheat equation (PBE)83 is often used by researchers when calculating RF in-
duced tissue temperature.
ρc
∂T
∂t
= ∇ · (k∇T ) + ρQ+ ρSAR− ρbcbρω(T − Tb), (5.2)
Here, T is the tissue temperature, t is the time, SAR is the specific absorption rate, ω
is the perfusion rate, ρ is the density of the medium the volume, c is the specific heat
capacity, k is the thermal conductivity, Q is the metabolic heat generation rate. The
subscript b denotes a blood property, respectively.
The calculated SAR is directly dependent on the tissue property values as inputs for
PBE. The dielectric parameters used were taken from the database of Gabriel et al. 34,35 .
The thermal parameters were derived from various databases as shown in Table 5.2. For
each calculation, we used the values of all the thermal parameters (specific heat capacity,
thermal conductivity, density and blood perfusion) from one database. In case that a
database, e.g. Lang and Erasmus MC, does not contain values of all parameters we took
the missing parameters from the ITIS database.
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5.2.3 Baseline and thermo-regulated tissue properties
If we compare thermal parameters with each other, we find small differences for density,
specific heat, and thermal conductivity among various databases. For perfusion, however,
differences are large because the literature values for blood perfusion are generally at
resting condition (baseline temperature: 37◦C), while values at high temperatures are
completely different due to thermoregulatory response of tissues under thermal stress.
For local hotspots above 20 W/kg psSAR10g, thermoregulated local perfusion is the most
important parameter determining the RF induced temperature increase64,71, and is also
the major tissue response to hyperthermia92. Thermoregulatory processes show typical
response times in the order of 10 minutes43. In the current study, we did not consider the
transient effect of thermoregulation, i.e. always the values of parameters at steady state
were used.
To consider the impact of local thermoregulation, data analysis was performed for:
Basal perfusion effectively modelling a completely dysfunctional thermoregulation, us-
ing the McIntosh and ITIS databases.
- Literature summary by McIntosh: McIntosh et al. standardized tissue thermal para-
meters by documenting 140 key papers and books and developed a database of the
thermal properties for around 50 human tissues72.
- ITIS Foundation tissue database: ITIS foundation took an inclusive approach and
incorporated all studies with varying approaches and degrees of accuracy after
eliminating studies with major flaws to increase the parameter sample size used.
This database provides the average values and information about the variability of
parameters49.
Thermoregulated perfusion for muscle, fat and skin:
- Sigma Hyperplan tissue database: These values are provided by the hyperthermia treat-
ment planning system HyperPlan and derived from the clinical application of deep
pelvic hyperthermia with the Sigma-60 applicator. Typical values of thermal con-
ductivity and perfusion are listed in Wust et al. 107 , and empirically obtained val-
ues created by hyperthermia model-treatment comparison are found in Sreenivasa
et al. 91 , Wust et al. 108 .
- Temperature-dependent model by Lang: Lang et al. 68 employed a temperature-dependent
blood perfusion model based on preclinical measurement data of Song et al. 90 to
improve the classical bio-heat term in PBE which assume a constant-rate blood per-
fusion within each tissue68. For each exposure scenario, we calculated the perfusion
value based on Lang model using the corresponding Tthresh in Table 5.1.
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- Erasmus MC H&N database: We calculated the effective perfusion for tumor, muscle
and fat from the measurement data obtained during deep head and neck (H&N)
HT treatments of nine patients that had interstitial catheters in the target region86.
The effective perfusion was reconstructed based on the thermal washout technique
from temperature decay measurements87,103.
In summary, we assume that at resting condition, the databases of McIntosh and ITIS
are more reliable because they are based on a large number of studies whereas, under
thermal stress and other conditions that may increase perfusion, the databases/models of
Erasmus MC, Hyperplan and Lang provide more reliable data as they take thermoregu-
lated perfusion into account. In the current study, we took the Erasmus MC properties
and exposure duration of 60 minutes as reference.
5.3 Results
5.3.1 Functional SAR limits SARTDFL: Influence of focus dia-
meter, exposure duration and tissue thermal parameters
Figure 5.2 shows the calculated SARTDFL for various available tissues in table 5.1. The
SARTDFL values were calculated assuming that tissues are uniformly heated. The figure
indicates that muscle has the lowest SARTDFL value among tissues, applying the basal
tissue property databases which are more comprehensive compared to thermoregulated
databases. The thermoregulated databases are limited for this comparison. It also indic-
ates that the SARTDFL increases significantly if the thermoregulated perfusion is applied.
The maximum variation in calculated SARTDFL is seen in muscle, which shows a 10 fold
increase in allowable SAR using the Erasmus MC tissue parameters rather than the lower
perfusion McIntosh database. Figure 5.3 shows the impact of focus diameter and thermal
tissue properties on the calculated SARTDFL in the muscle, fat and skin. These three
tissues were selected as thermal hotspots occur most commonly in them during medical
applications such as hyperthermia and MRI74 and literature values are more abundant.
The figures demonstrate the exponential increase in SARTDFL with decreasing sphere
diameter, ie. the threshold allowable SAR increases 180 fold as spherical hotspot region
decreases from 20 cm to 0.5 cm diameter. The figures also indicate that the variations
in the calculated SAR due to the differences in thermal tissue properties among various
databases are larger for bigger spheres, where the tissue blood perfusion is the dominant
parameter, and decreases in small spheres, where the blood perfusion dominance disap-
pears at the benefit of thermal conduction (figure 5.3). The maximum variation in the
calculated SARTDFL due to differences in thermal parameters over various databases is
in a sphere of 20 cm diameter in muscle, with a 12.5 fold increase using thermoregulated
perfusion (Erasmus MC database) vs. basal perfusion (McIntosh database). The impact of
surrounding tissue on the temperature at the center of sphere is less for bigger spheres and
by using thermoregulated perfusion. Figure 5.4 shows the impact of exposure duration
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Figure 5.2: Comparison of SARTDFL among various tissues after 60 minutes expos-
ure, using various tissue property databases. The SARTDFL values were
calculated in the worst case assuming that the focus volume is uniformly
heated.
on the calculated SAR threshold. It indicates that by reduction of exposure duration, the
calculated SARTDFL in spheres increases, which is caused by the higher thresholds of tem-
perature increase in tissues, i.e. according to the CEM43◦C definition, shorter exposure
duration requires higher temperature for the same CEM43◦C thermal dose (equation 5.1).
This increase is more pronounced in larger spheres than in small spheres. For exposure
duration less than 10 min (thermoregulatory response time) only the basal thermal tissue
properties were applied, i.e. McIntosh. The calculated SAR limit for muscle using McIn-
tosh database increases by 10 fold by reducing the exposure duration from 60 to 5 min in
a sphere of 20 cm diameter. This increase is lower for smaller spheres.
5.3.2 Validation of the SAR limits using clinical conditions
To validate the calculated SAR against clinical data, we compared our results to the sim-
ulated SAR for a realistic scenario in hyperthermia application. In our previous study we
used detailed numerical EM and thermal simulations and showed that psSAR10g=191.5
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Figure 5.3: Impact of focus diameter on the SARTDFL for muscle, fat and skin using
various databases for thermal tissue properties. The SARTDFL values were
calculated for exposure duration of 60 minutes.
W/kg is required to induce a 6◦C temperature increase in 10 g of muscle during 60 min
of hyperthermia treatment in H&N3. 10 g of muscle is equivalent to a sphere of 2.6 cm
diameter. The calculated SAR in a sphere of 2.6 cm using thermoregulated Erasmus MC
database is 218.3 W/kg, which nicely matched the simulated psSAR10g (12% difference).
The expanded uncertainty of the simulated result due to uncertainties in the modeling
parameters was 23%. This indicates that the differences between the calculated versus sim-
ulated SAR (12%) is less than the uncertainty of numerical modeling (23%). We therefore
conclude that our calculated SAR limits provide valid values.
5.3.3 Thermal-dose-based basic restriction definition procedure
Finally, we provide a decision making flowchart that demonstrates instructions to calcu-
late the SAR limit (figure 5.5). Hereto we first need to determine the size of hotspot
volume in a specific tissue which is estimated by the RF wavelength in a lossy dielec-
tric or tissue106. For hotspots with diameter larger than 5 cm, the blood perfusion is
5.4 Discussion 75
Figure 5.4: Impact of exposure duration on the SARTDFL after 60, 30, 15 and 5
minutes exposure in spheres of 20, 5, 1 and 0.5 cm diameter in muscle.
The results are calculated for only basal (McIntosh) and thermoregulated
(Erasmus MC) perfusions, considering 10 minutes delay in thermoregulat-
ory process of tissue, i.e. there is no thermoregulated perfusion for exposure
duration <10 min.
the most influential parameter. Therefore, thermal tissue properties under thermal stress
(e.g., ErasmusMC, Hyperplan and Lang databases) should be used to calculate SAR when
the exposure duration is longer than 10 minutes, and the thermoregulatory response of
tissue is activated43. This excludes hotspots with a diameter less than 5 cm, since thermal
conductivity is the determinant parameter that has similar values amongst the property
databases. If the exposure duration is shorter than 10 minutes, we propose to use the
databases for basal/resting conditions (e.g., McIntosh and ITIS).
5.4 Discussion
The current ICNIRP55 and IEEE57 safety guidelines on human exposure to RF EMF,
incorporate large safety factors to protect against any potential adverse health effect. The
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Thermoregulated
perfusion
No 
Exposure frequency
Basal properties
Yes
Yes 
Exposure 
duration
>10 min 
Hotspot size
>5 cm
No 
Figure 5.5: Instructions to calculate SARTDFL limit.
selection of a safety factor is based on informed expert opinion rather than a rigorous
quantitative process. Therefore, the magnitude of safety for a certain localized exposure
condition is unknown. The main objective of the current study was to assess and evaluate
the relevance of the incorporated safety factor in the current basic restriction for various
local exposure scenarios. To achieve this goal, we calculated the functional SAR limits
(SARTDFL) based on the lowest thermal dose, in units of CEM43
◦C, that result in local
acute tissue damage, derived from our recent study97. We translated these tissue specific
CEM43◦C limits into SARTDFL by solving the Pennes bioheat equation using MATLAB
PDE solver. SARTDFL was calculated in a sphere of different diameters (0.5, 1, 2, 5, 10,
15, 20 cm) which represents localized RF hotspot for various exposure durations (60, 30,
15 and 5 min) and various databases of thermal tissue properties. Our results show that
in order to arrive at the basic restrictions in the common generic guidelines, SARTDFL
values for muscle are lowered by safety factors shown in table 5.3. Muscle was selected
because comparison of the calculated SARTDFL among various tissues shows that muscle
has the lowest limit (figure 5.2). In addition, thermal hotspots occur most commonly in
muscle during medical applications such as hyperthermia and MRI. The magnitude of the
safety factor in table 5.3 ranges from 10.9 to 31.2 for localized psSAR10g. The lower and
upper bounds of the range were obtained for exposure durations of 60 min and 10 min
(= typical delay of the thermoregulatory process) using thermoregulated perfusion from
the Erasmus MC database, i.e. the reference database in this study. Therefore, the real
incorporated safety factor between the functional SAR limits and the basic restrictions
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varies significantly depending on the size of thermal hotspot and exposure duration. Table
5.3 also shows the ratio between SARTDFL and MRI guidelines (as an important guideline
for a EMF-based medical application). The results obtained can even be regarded as con-
servative estimates since we employed the lowest CEM43◦C value that has been reported
for thermal tissue damage amongst all available data for human and animal species.
We also assessed the sensitivity of the calculated SARTDFL to exposure parameters, i.e.
the size of hotspot, exposure duration and thermal tissue properties for muscle, fat and
skin (the tissues where thermal hotspots are most commonly located). Our results show
that the size of hotspot has an essential role on the SAR, i.e. the calculated SARTDFL
increases exponentially by decreasing the focus diameter (figure 5.3). The reason for this
is the increasing surface-to-volume ratio with decreasing sphere diameter which leads
to a stronger dissipation of the generated heat into surrounding tissue and thus a higher
required SAR for inducing temperature inside the sphere. In addition, the temperature in-
creases more rapidly in smaller spheres, which leads to a larger ∂T
∂t
in PBE (equation 5.2)
and consequently to a higher SARTDFL value. This finding explains and confirms the
higher delivered SAR level of deep hyperthermia treatment in head and neck (H&N) re-
gion ( 75 W/kg) compared to pelvic region ( 16 W/kg) which is mainly due to smaller
size of tumor/target in H&N region82. This finding also confirms the relationship between
the SAR and tumor size in magnetic nanoparticle hyperthermia reported in Dutz and
Hergt 24 . To assess sensitivity of the results to the tissue properties, we used various avail-
able tissue property databases. The results show that thermoregulated perfusion under
thermal stress significantly raises SARTDFL compared to basal perfusion at resting con-
dition. In a sphere of 20 cm in muscle, it is a factor of 12.5 fold increase in SARTDFL
(maximum variation). In smaller heating volumes, where the surface-to-volume ratio is
big, perfusive effects are almost non-existent, and thus thermal conductivity becomes the
primary mechanism of heat transport (figure 5.3). Reduction of exposure duration results
in higher thresholds of safe temperature-increase and consequently to a maximum of 10
fold increase in SARTDFL (figure 5.4).
Comparison of the calculated SARTDFL values in the current study with the simulated
SAR from numerical calculations and experimental investigations in hyperthermia ap-
plication shows that the calculated results in the current study are consistent with the
simulations.
To examine whether our results are in an acceptable range, we investigated whether the
calculated SARTDFL limits in the current study are exceeded by SAR values obtained in
medical applications such as hyperthermia treatment and MRI scanning. A retrospective
study based on the treatment reports of 35 patients treated with deep hyperthermia in
pelvic region, controlled by extensive treatment planning showed that apart from a few
outliers, the average SAR level at patient pain complaints (hotspots) appears to be relat-
ively constant at approximately 230 W/kg9. The SAR peak volume was around 35 ml for
an average patient and covers most SAR peak locations in the patient model. This 35 ml,
in the worst case, is equal to an integrated sphere with diameter of 4 cm. The calculated
SAR threshold for a sphere of 4 cm diameter in muscle for 60 minutes exposure is 172.9
W/kg. However, the authors stated that the peak SAR volume is distributed over mul-
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tiple sub volumes, which are spread over multiple regions, thereby resulting in a higher
SARTDFL. Therefore, depending on how the peak SAR volumes are distributed over the
patients body, the calculated SARTDFL might still be in agreement with the clinical ob-
served maximum. If the hotspot volume would be divided into sub-regions equivalent to
spheres with diameters ≤2.4 cm, the SARTDFL thresholds would not be exceeded in the
clinic. Furthermore, the absorbed energy in six human models in different Z-positions
(head to knees) within a 1.5T bodycoil MRI system, was assessed by performing a de-
tailed simulation study. The results show that local SAR in terms of psSAR10g in the
normal and first-level controlled MRI operation mode may exceed the limits as defined
in56 for local transmit coils by more than a factor of three, i.e. reach 120 W/kg73. This
SAR level was obtained in obese adult models, i.e. in fat tissue. 10g of fat is equal to a
sphere of 2.7 cm diameter, for which the calculated SARTDFL threshold is 255.7 W/kg
from 5 minutes RF exposure during MRI exam (Note that only a small part of the MRI
exam is devoted to RF exposure and the rest is for scanning). Therefore, the simulated
induced SAR during MRI application is well below (by a factor of 2) the calculated SAR
threshold which is associated to thermal damage in tissues.
In the current study we had a number of assumptions. Firstly, we assumed a constant tem-
perature over 60 minutes of treatment. It is a conservative approach (worst case) because
heating is not expected to be either spatially or temporally constant during the entire
hyperthermia session. In case of shorter exposure duration, the temperature and also the
calculated SAR will be higher according to the CEM43◦C definition 5.2. Secondly, the
rate of cell death (R) for temperature below the breakpoint (43(◦C)) was assumed to be
1/4 for calculation of thermal dose according to CEM43◦C definition. However, there is
uncertainty about the slope of the Arrhenius plot below the breakpoint. Most rodent data,
however, suggest that the R-value below the breakpoint is between 1/4 and 1/620. We
investigated the influence of the R-value on the calculated SAR by performing the thermal
dose calculation using R=1/2 (assuming the same value as above the breakpoint) and 1/6
(the lowest reported value for rodent). |∆SARTDfunc limit| was obtained by comparing the
results using R=1/4 as reference. The result of our investigation shows 2.1% reduction
(R=1/6) and 12.1 % (R=1/2) increase in the calculated SARTDFL, averaged over tissues
indicated in Table5.1. Thirdly, no other temperature related effects were considered, for
example, change of SAR-distribution due to thermoregulation dependent dielectric para-
meter. Finally, at diameters of 5 cm and exposure duration of 10 min, a transition zone
from basal to thermoregulated properties is present, resulting in more uncertainty in the
SARTDFL at this zone.
5.5 Conclusions
Based on the available data on CEM43◦C thermal thresholds for tissue damage, we calcu-
lated the safety factor between the established functional SAR limits (SARTDFL) and the
common basic restrictions in ICNIRP and IEEE guidelines for various localized exposure
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scenarios. We found that the margin of safety factor for localized SAR averaged over any
10 g of tissue (psSAR10g) is in the range of (10.9 - 31.2), depending on the size of thermal
hotspot and exposure duration. The benefit of changing from subjective to objective safety
factor is that it facilitates decision making on how much the responsible investigator can
increase local SAR exposure with an acceptable risk of thermal damage. Our analysis
provides clear indications of functional SAR limit for different exposure scenarios, for in-
stance 150 W/kg in muscle for hyperthermia (60 min exposure and a target of 4 cm in
diameter). This value change exponentially with the size of heating volume; hence, the
smaller the target is, the higher SAR is needed to induce the same heat. The impact of
(delayed) temperature-regulated perfusion is essential and raises SAR limits up to 12.5
fold compared to the value based on basal perfusion in a resting condition. More research
on local thermoregulatory and tissue damage processes is therefore of high importance.
The current study can form the basis for further discussion on the use of functional loc-
alized SAR limits that are more exposure derived than the current generic limits. Such
an approach might be beneficial for patients undergoing MRI to detect abnormalities in
anatomy. In hyperthermia treatments the calculated limitations have potential to be used
for improved control of RF-delivery to reduce the probability of thermal toxicity, while
maintaining maximum probability of tumor control.
CHAPTER 6
General discussion and perspectives
82 General discussion and perspectives
6.1 General discussion
The basic restrictions (BRs) on localized exposure to RF EMF have been developed to
avoid excessive adverse tissue heating (< 1◦C) in humans since until now thermal effects
are the only established adverse health effect at RF frequency range of EMF exposure55,57.
These guidelines are currently based on the limited data, e.g. experimental assessments
in animals or epidemiological studies using approximated human anatomical models. To
account for uncertainties in the data, the BRs are defined by applying large, conservative,
safety factors. In this thesis, the quality of the BRs was verified by exploiting the unique
opportunity that medical applications provide. The applied fields in medical applications
such as hyperthermia treatment of cancer are in general orders of magnitude higher than
those defined in the guidelines even for the upper tier, i.e. occupational environment.
Therefore, there is a special possibility to establish dose-response relationship for humans
exposed to prolonged intense RF EMF during hyperthermia. The results presented in this
thesis confirm that the BRs are indeed conservative. Hence, below the exposure limits of
the guidelines no adverse effect was noted. Moreover, also no indication of a serious acute
effect was observed upon exceeding the guidelines during hyperthermia. This data en-
couraged us to investigate the possibility of introducing functional SAR limits which are
associated to the lowest thermal dose above which thermal tissue damage take place.
This thesis provides knowledge that could contribute to the international ongoing discus-
sion for tailoring the existing BRs based on the human data available for thermal dose
thresholds to induce tissue toxicity. The experience obtained during the medical applica-
tion of tissue heating provides an excellent and unique source of human data on the dose
thresholds for thermal damage. Subsequently, the enhanced understanding of the thermal
tissue damaging process can be exploited to derive EMF exposure guidelines based on
actual functional SAR limits observed in humans, which will enable safe use of diagnostic
and therapeutic application of EMF at optimized (higher) SAR levels required in, for
instance, high intensity MR imaging.
Within the scope of this thesis, four main shortcomings in the development of the localized
BRs have been addressed aimed at providing stronger foundations:
1. The BRs have been derived from numerical simulations that approximated the human
morphology with generic phantoms. In Chapter 2, we demonstrated that morphology
is an important source of uncertainty in RF dosimetric studies. Therefore, dosimetric
analysis dealing with RF dose at a specific region in the brain must be based upon
the individual morphology.
In order to define general local BRs, it is essential to extend the sample of the
selected head models in this thesis to a representative group of anatomies for the
general population that covers the full range of personal features such as age, race,
weight and head size. An additional valuable use of this data would be to determine
the influence of the personal features of individuals on SAR variations which would
help, in particular, epidemiological researchers to reduce uncertainty by applying
appropriate matching variables between cases and controls. In addition, this research
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should be extended for modern mobile phone models and other RF exposure sources,
or generic sources such as plane waves.
2. The BRs have been developed based on established thermal effects from animal experi-
ments. Translation of the results from animals to humans is difficult, contributing to
a rather unsystematic approach in setting the safety factors. This thesis provides pi-
oneering human data on EMF and thermal dose-response relationships in the brain
and the eyes, as the most critical organs, when humans are exposed to prolonged
intense RF EMF during hyperthermia treatment.
The induced local SAR in tissues during hyperthermia can reach levels of 200-300
W/kg at which a substantial probability exists that thermal tissue damage occurs.
Evaluations of acute effects by the common toxicity criteria (CTC) scores revealed
no indication of a serious acute effect upon exceeding the BRs (i.e. 10 W/kg) by
up to 14 (brain) and 10 (eyes) times. Such rare and initial dose-response data is of
great potential value for health and standards agencies to tailor the BRs based on
the functional change in humans that is to be prevented and the level of safety to en-
sure prevention. Expanding upon this data, a unique library of associations between
exposure-level and effect-level for human exposure conditions can be created for con-
tinuously tailoring the localized BRs. The CTC scores in this thesis were used as
quantitative assessment of humans well-being and functional changes after exposure
to very high EMF, i.e. subjective complaint scores. Nevertheless, since acute toxicity
is scored based on patient responses to physicians, it does not rule out sub-clinical
adverse health effects. Therefore, additional research is required to objectively study
the more subtle functional changes in a prospective and protocolized way.
3. The BRs are lowered by conservative safety factors which were selected based on in-
formed expert opinion rather than a rigorous quantitative process. The magnitude
of safety factor for various localized exposure scenarios and various tissues is un-
known. This thesis provides clear guidelines for quantifying the incorporated safety
factor for various exposure scenarios and various tissues. In Chapter 5 we showed
that in order to arrive at the exposure level of the localized BRs, the functional SAR
limits are lowered by large safety factors, i.e. up to 31.2 depending on exposure dur-
ation and frequency. The functional SAR limits in this research are calculated using
the Pennes bioheat equation based on the lowest thermal dose that leads to tissue
damage available in literature for humans and animal species. Incorporation of the
thermoregulated perfusion is the most influential parameter for local temperature
increase assessment and related thermal tissue damage. More research on local ther-
moregulatory and tissue damage processes is therefore of high importance. Special
attention must be paid on people with disabled or partially dysfunctional perfusion
abilities (e.g., the elderly, diabetics) or heat sensation. Experimental validation of
the presented results on the functional SAR values is required in future work.
4. The BRs for localized exposure have been originally derived from the established BRs
for whole-body exposure55,57. The underlying process of this derivation of the loc-
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alized BRs in the common guidelines is very weak, lacks details and is unclear. In
Chapter 5 this thesis describes that local exposures guidelines should not be de-
rived from whole body exposure guidelines because the size of the applied averaging
volume has an essential impact on the SAR limits. This outcome clearly shows the
relevance for calculating the functional exposure levels and on the choice of the
mathematical model. Since the averaging volume over 10 g of tissue (as defined in
the localized BRs) is much smaller than the whole-body volume, the required SAR
for inducing the same heating in a tissue is dramatically different in localized versus
whole-body exposure. Thus, localized SAR values can be much larger than whole-
body SAR not only because of the higher heat tolerance of tissues under localized
exposure, but also because of the smaller size of the averaging volume. Therefore,
the principles for defining the whole-body BRs cannot be applied as the basis for
defining the localized BRs. Moreover, the results of this thesis stress the high impact
of the averaging size for the localized BRs, which is a part of an ongoing discussion
with respect to 1 gram or 10 gram averaging mass.
6.2 Outlook and Future work
For future safety concepts, we suggest to use thermal dose models rather than SAR limits.
Hence, we advise defining limits on the localized peak temperature increase for specified
durations of exposure. Such an approach may be challenging due to the complexity and
uncertainty in the thermal parameter space. Nevertheless, we believe that having a better
surrogate for actual tissue damage outweighs this larger uncertainty and may become
more useful in the future than SAR limitations, which have very limited correlation to
tissue temperature and tissue damage. In this respect, Chapter 4 shows that there is a
larger uncertainty in the linear correlation between SAR and temperature than in tem-
perature assessment. This approach has been applied to some extend in the last version
of the magnetic resonance (MR) guidelines IEC 56 : to prevent local tissue damage in the
body, the tolerated local tissue temperature rise of the patient is restricted to maximum
40◦C by the MR equipment in the first level controlled operating mode. However, there
are no guidelines on how to control these limits and also not on exposure duration at
40◦C. Compliance to the temperature limits is reached by limiting the SAR. Major prob-
lem in temperature assessments is the implementation of the effect of thermoregulation.
Special attention should be given to fill the existing gaps in modeling the local tissue ther-
moregulation, i.e. temperature-dependent blood perfusion and heat conduction models.
Improvement of these models requires measurement of thermal data to tune the models
to measurements to improve the reliability of predictions. Unfortunately, experimental
assessments in humans are rare and usually date back some decades. Recent advances in
non-invasive MR thermometry (MRT) provide great opportunities to identify heterogen-
eities, anisotropies, and temperature dependent tissue properties in various anatomies.
Thermal tissue property values can be derived from this data by application of optim-
ization techniques to invasive temperature measurement data of patients treated with
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hyperthermia100. Obtaining such valuable inter- and intra-individual human data would
enable assessment and improvement of the uncertainty of modelling results.
The analysis in this thesis was restricted to macroscopic, i.e. tissue-specific exposure as-
sessments. Various numerical approaches can be used at a microscopic scale to identify and
assess possible interaction mechanisms between biological cells and an incident EMF. Al-
though a considerable number of research groups worldwide have worked on the physiolo-
gical effects of EMF and their influence in the biological response, relatively little is
known about the possible interaction mechanisms and the underlying modified biological
processes by an incident field. In fact, it is unclear which exposure conditions can trigger
a certain positive response and avoid possible damage in cells and tissues. Detailed dosi-
metry combined with experimental validation is crucial to fill this knowledge gap on the
biological explanation of EMF effects. Similarly, rigorous dosimetry is crucial in experi-
mental biological cell exposure studies to report not only the external incident fields to
Petri-dishes but also the induced internal, local field strengths, current densities, absorbed
energy, and temperature increase to identify the biological interaction with EMF. In re-
cent years, the advance in computer power has provided extraordinary capabilities for the
progress of numerical computational simulations to support identification of interaction
mechanisms, which are mostly identified by experimental research so far.
The availability of advanced modeling tools suitable to investigate the health effects of
RF exposure enables us to define more refined BRs to allow safe and beneficial use of
EM. After decades of searching for possible harmful effects, more attention should be
paid to explore the potentially beneficial effects of EM exposures on humans and to the
development of (medical) applications that take advantage of the well-identified beneficial
effects such as bone formation46,54, wound healing32,62 and nerve regeneration18,69.
Investigating “potential” adverse effects of EMF is like searching for a needle in a hay-
stack, while not knowing whether there is a needle in the haystack. It is nearly impossible
to find an effect which is not well-identified under un-controlled conditions. Fortunately,
EMF-based medical applications such as hyperthermia, MRI and TMS, in which huge
number of people are being exposed to high intensity EMF and are monitored by medical
experts long time after the exposure, provide the unique opportunity to capture “po-
tential” adverse health effects and to create a very valuable library of human data for
tailoring the EM safety guidelines. Therefore, EMF-based medical applications may well
be the best field to advance in the tailoring of the BRs by relying on serendipity of experts
to at least start looking in the right haystack.
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Summary
88 Summary
Exposure to radio-frequency (RF) electromagnetic fields (EMF) is unavoidable in today’s
modern life. This exposure is growing mainly because of rapid growth in telecommu-
nication systems. Awareness of the possible risks of exposure to EMF has raised public
concern. To avoid any potential adverse health effect, international organizations of IC-
NIRP 55 and IEEE 57 have developed basic restrictions (BRs) on specific absorption rate
(SAR) for human exposure to RF EMF. These restrictions were derived based on limited
data, i.e. experimental assessments (almost entirely) in animals or dose assessment using
generic phantoms (approximated human anatomy). In order to account for uncertainties
in the data and to provide a sufficient level of safety, the limits are lowered by large safety
factors which were selected based on expert opinion rather than a rigorous quantitative
process. The safety factors are not quantified for various exposure scenarios.
In view of the lack of knowledge on the incorporated safety factor, and in the light of
unique opportunity that medical applications can provide to establish dose-response rela-
tionship for humans, the aim of this thesis is to explore the relevance of the current BRs
for functional tissue changes and to tailor SAR limits for localized exposure above which
tissue damage takes place. This thesis, by means of advanced simulation tools, shows that
the current restrictions on local exposure to RF EMF are conservative and should be
more refined based on accurate dosimetry and useful data on experimental assessments
in humans.
Chapter 1 starts with a general introduction on the interaction of RF EMF with human
tissues and on the established adverse health effects. It describes the basic restrictions
and incorporated safety factors in the common guidelines and ends with the outline of
this thesis.
Chapter 2 indicates that RF dose calculation in the brain is considerably influenced by
head morphology. Therefore, the reported association between the risk for brain tumor
induction and the (cumulative) absorbed RF dose in the brain calculated for exposure
to a mobile phone to a generic head phantom, as reported in the recent epidemiological
Interphone studies, is subject of a large uncertainty (max: 16.8 dB). From the work re-
ported in this chapter it follows that estimation of local absorbed dose in the brain must
be on the basis of the real morphology and not on generic phantoms in RF dosimetric
studies.
In Chapter 3, 4, we took the unique advantage of medical applications in applying high
EMF on humans to build pioneering quantitative human data on the dose-response rela-
tionship in the brain and the eyes, as the most critical organs for the safety guidelines.
We analysed the association of high induced EM (brain and eyes) and thermal (eyes) dose
with reported acute effects in patients treated with hyperthermia for cancer in the head
and neck region. The calculated doses were subsequently related to the recorded functional
adverse effects based on the Common Toxicity Criteria (CTC) scores, i.e. a standardized
classification of adverse effects used in cancer therapy evaluation. Evaluations of acute
effects revealed no indication of a serious acute effect upon exceeding the BRs (i.e. 10
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W/kg) by up to 14 (brain) and 10 (eyes) times. At present, human data is very scarce
and standards rely almost entirely on much less satisfactory animal experimental data.
Such initial human dose-response data is of great potential value for health and stand-
ards agencies to tailor the BRs based on the functional change in humans that is to be
prevented and the level of safety to ensure prevention.
The basis for the localized BRs is to keep local tissue temperature rises under 1◦C in hu-
mans. However, thermal tissue damage occurs at much higher thermal doses. Literature
values for maximum tolerable thermal doses of various tissues are available110. Therefore,
in Chapter 5 we explored how much the SAR limits can be increased before thermal
tissue damage occurs. This Chapter provides clear indications of functional SAR limits
for various exposure scenarios based on the lowest thermal dose that result in local acute
tissue damage available in literature. The calculated safety factor as a ratio between the
functional SAR limits and the local BRs can be up to 31.2 depending on the exposure
duration and exposure frequency which determines the size of the heated volume. Ther-
moregulated local perfusion, as the major tissue response to heat, is the most important
parameter for RF induced temperature increase assessment. This research presents an ap-
proach to establish the guidelines dedicated to a specific exposure scenario, i.e. exposure-
specific SAR limits, to improve the functionality of exposure purpose.
All in all, the numerical results obtained in this thesis provide additional support to refine
the localized BRs based on the functional change in humans to allow safe and beneficial
use of RF EMF. This thesis provides knowledge that contributes to further discussion
on the use of functional localized SAR limits that are more exposure derived than the
current generic limits.

Samenvatting
In de hedendaagse samenleving is blootstelling aan radiofrequentie (RF) elektromagne-
tische velden (EMV) is onvermijdelijk. Daarbij neemt de blootstelling nog steeds toe als
gevolg van de snelle toename van het telecommunicatie gebruik. De gedwongen blootstel-
ling aan EMV gekoppeld aan onduidelijkheid over het wel of niet bestaan van schadelijke
effecten, heeft bij de bevolking geleid (en leidt nog steeds) tot bezorgheid over mogelijke
ongewenste gezondheidsrisico’s. Om nadelige gevolgen voor de gezondheid te voorkomen,
zijn door internationale organisaties (ICNIRPICNIRP 55 en IEEEIEEE 57) blootstellings-
normen ontwikkeld. Deze zogenoemde basisrestricties (BRs) geven aan hoeveel RF-EMV
energie in W/kg door menselijk lichaam geabsorbeerd mag worden en wordt aangegeven
als “specic absorption rate”(SAR). De absolute SAR-waarden van de toegestane bloot-
stelling zijn gebaseerd op beperkte experimentele gegevens, die grotendeels verkregen zijn
uit experimentele bij dieren of modelberekeningen en metingen met behulp van generieke
fantomen. De aldus vastgestelde basisrestricties kennen een grote mate van onzekerheid.
Om toch een hoog niveau van betrouwbare veilighed te bieden, worden de limieten ver-
laagd met grote veiligheidsfactoren, waarbij de grootte van de veiligheidsfactor vooral
gebaseerd is op de mening van experts en niet kwantitief is vastgesteld via een rigorous
risico analyse. Daarnaast wordt geen onderscheid gemaakt tussen verschillende blootstel-
lingscondities.
Het onderzoek gerapporteerd binnen dit proefschrift gaat in op de unieke kans die me-
dische toepassingen van RF-EMV bieden om de dosis-respons relatie voor de mens vast
te stellen, en op basis van deze bij mensen verkregen gegevens een veiligheidsfactor vast
te stellen die effectief beschermd, maar niet overbeschermd. In het proefschrift wordt de
relevantie van de huidige BRs aan de hand van functionele veranderingen van menselijk
weefsel verkend. Daarnaast is voor lokale blootstelling gekeken hoeveel ruimte er bestaat
tussen de bestaande SAR limieten en de berekende SAR grenswaarde voor weefselbescha-
diging zoals gevonden bij medische toepassing. Het onderzoek binnen dit proefschrift laat
zien dat de huidige beperkingen voor lokale blootstelling aan RF-EMV conservatief zijn
en meer accuraat en speficifiek kunnen worden, als zij worden gebaseerd op nauwkeurige
dosimetrie en analyse van bijwerkingen bij RF-EMV blootstelling van medische toepas-
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singen bij de mens.
Hoofdstuk 1 begint met een algemene inleiding over EMV en op de interactie van RF-
EMV met het menselijke lichaam en de vastgestelde schadelijke gezondheidseffecten. Het
beschrijft de basisrestricties en benoemt de vastgestelde veiligheid factoren zoals vermeldt
in de internationale richtlijnen voor blootstelling aan RF-EMV. Het eindigt met indeling
van dit proefschrift.
Hoofdstuk 2 laat zien dat RF berekening van de dosis in de hersenen sterk wordt bein-
vloed door de morfologie van het hoofd. De consequentie van deze bevinding is dat het
mogelijk verband tussen geabsorbeerde RF dosis in de hersenen en het risico op induc-
tie van een hersentumor zoals gerapporteerd voor de recente Intercom epidemiologische
studies, een hoge mate van onzekerheid kent. De RF-EMV dosis berekend voor een alge-
mene hoofd fantoom bij blootstelling aan een mobiele telefoon en kan tot max 16.8 dB
afwijken. Schatting van de lokale geabsorbeerde RF-EMV dosis in de hersenen kan alleen
nauwkeurig op basis van de werkelijke morfologie en kan niet bepaald worden met RF
dosimetrische onderzoek op generieke fantomen.
In Hoofdstuk 3, 4 is de toegang die wij hebben tot de medische toepassing van hyper-
thermie benut om data te analyseren van patienten die blootgesteld zijn aan zeer hoge
RF-EMV intentsiteiten voor de behandeling van kanker. Deze patient gegevens bieden een
unieke mogelijkheid op kwantitatieve analyse van een mogelijke dosis-responsrelatie in de
meest gevoelige organen van een mens, namelijk hersenen en ogen. In de richtlijnen voor
veilige blootstellingslimieten worden hersenen en ogen als de meest kritische organen be-
schouwd. In beide hoofdstukken zijn de gegevens geanalyseerd op een mogelijke correlatie
tussen geinduceerde RF-EMV (hersenen en de ogen) en thermische (ogen) dosis met de
gerapporteerde acute effect bij patienten tijdens hun behandeling met hyperthermie voor
kanker in het hoofd-halsgebied. De berekende doses werden vervolgens gerelateerd aan
de geregistreerde functionele nadelige bijwerkingen volgens de Common Toxicity Criteria
(CTC) scores, d.w.z. een gestandaardiseerde classificatie waarmee bijwerkingen van een
kankerbehandeling wordt geevalueerd. Uit de evaluatie van de verkregen patient gegevens
volgde dat de BRs (d.w.z. 10 W/kg) overschreden kan worden tot ten minste een factor
10 (hersenen) dan wel 14 (ogen) Zonder dat een ernstige acute bijwerking (CTC3)werd
geconstateerd. Nog steeds zijn gegevens over de dosis-effect relatie bij blootsteling van een
mens aan hoge dosis RF-EMV zeer schaars. Dientengevolge zijn alle richtlijnen voor RF-
EMV blootstelling bijna volledig gebaseerd dierexperimentele gegevens met de daarbijbe-
horende onzekerheid. De Hoofdstuk 3, 4 gerapporteerde initiele dosis-respons gegevens
geeft nieuwe inzichten voor de vaststelling van nieuwe op humane gegevens gebaseerde
richtlijnen door gezondheidsorganisaties en overheidsagentschappen, waarbij de BRs spe-
cifiek kan zijn voor de beoogde functionele veranderingen bij de mens en een effectief
niveau van veiligen geboden wordt.
Het doel van de gelokaliseerde BRs is om de lokale weefsel temperatuur stijging te be-
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perken tot maximaal 1◦C. Echter, uit de beschikbare wetenschappelijk literatuur volgt
dat weefselbeschadiging als gevolg van verwarming pas bij een veel hogere thermische
dosis ontstaat, en verschild per weefseltype110. Daarom is in Hoofdstuk 5 is een andere
benadering voor het bepalen van de SAR-limieten gevolgd. Per weefseltype is de, in de
literatuur, laagst gerapporteerde thermische dosis voor lokaal acute weefselschade, vast-
gesteld. Vervolgens is deze thermisch dosis vertaald naar de maximaal toegestane SAR
waarde, waarbij rekening wordt gehouden met de specifieke RF-EMV blootstellingscon-
dities. De uitkomst is dan een functionele SAR limiet die variabel is en afhangt van de
precieze blootstellingsduur en de frequentie van het RF-EMV (de frequentie bepaalt de
grootte van het verhitte volume). Het onderzoek toont aan dat de op deze wijze berekende
functionele SAR limiet tot een factor 31.2 hoger kan zijn dan de SAR limiet bepaalt vol-
gens de conventionele BRs methodiek. Voor het vaststellen van de functionele SAR limiet,
is warmte afvoer via de, temperatuur afhankelijke, weefsel doorbloeding, bepalend voor de
uiteindelijke temperatuurstijging. Het model van een functionele SAR limiet is een eerste
aanzet om richtlijnen voor RF-EMV blootstelling op te stellen die specieke gericht zijn
op een toepassing zoals hyperthermie of MRI, dat wil zeggen blootstelling aan specieke
SAR limieten vast te stellen, met als doel de functionaliteit van de blootstelling te maxi-
maliseren.
Het onderzoek in dit proefschrift laat zien dat de veiligheidsfactor in de bestaande BRs
voor lokale blootstelling weinig specifiek is. Door rekening te houden met de blootstellings-
conditie kan de limiet voor de toegestane SAR waarde voor veilig en nuttig gebruik van
RF EMV, veel specifieker bepaald worden. Hopenlijk stimuleert dit proefschrift vervolg
onderzoek naar functionele gelokaliseerde SAR limieten die meer blootstellings speficiek
zijn dan de huidige generieke richtlijnen.
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